JPH0533929B2 - - Google Patents
Info
- Publication number
- JPH0533929B2 JPH0533929B2 JP18134086A JP18134086A JPH0533929B2 JP H0533929 B2 JPH0533929 B2 JP H0533929B2 JP 18134086 A JP18134086 A JP 18134086A JP 18134086 A JP18134086 A JP 18134086A JP H0533929 B2 JPH0533929 B2 JP H0533929B2
- Authority
- JP
- Japan
- Prior art keywords
- drug
- transdermal
- absorption enhancer
- patch
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229940079593 drug Drugs 0.000 claims description 144
- 239000003814 drug Substances 0.000 claims description 144
- 238000010521 absorption reaction Methods 0.000 claims description 98
- 238000002360 preparation method Methods 0.000 claims description 94
- 239000003623 enhancer Substances 0.000 claims description 78
- 230000001070 adhesive effect Effects 0.000 claims description 31
- 239000000853 adhesive Substances 0.000 claims description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- 239000002674 ointment Substances 0.000 claims description 23
- 239000000203 mixture Substances 0.000 claims description 20
- 229920001577 copolymer Polymers 0.000 claims description 17
- 239000000829 suppository Substances 0.000 claims description 17
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 15
- 239000000194 fatty acid Substances 0.000 claims description 15
- 229930195729 fatty acid Natural products 0.000 claims description 15
- 238000009472 formulation Methods 0.000 claims description 15
- 125000004432 carbon atom Chemical group C* 0.000 claims description 13
- 150000004665 fatty acids Chemical class 0.000 claims description 13
- 239000000178 monomer Substances 0.000 claims description 12
- 239000006071 cream Substances 0.000 claims description 9
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 6
- 229920001971 elastomer Polymers 0.000 claims description 5
- 239000003889 eye drop Substances 0.000 claims description 5
- 239000005060 rubber Substances 0.000 claims description 5
- 229940012356 eye drops Drugs 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 238000006116 polymerization reaction Methods 0.000 claims description 3
- 239000004820 Pressure-sensitive adhesive Substances 0.000 claims description 2
- 239000007923 nasal drop Substances 0.000 claims description 2
- 229940100662 nasal drops Drugs 0.000 claims description 2
- 239000003522 acrylic cement Substances 0.000 claims 1
- 125000005313 fatty acid group Chemical group 0.000 claims 1
- 230000000052 comparative effect Effects 0.000 description 34
- -1 dicarboxylic acid ester Chemical class 0.000 description 22
- 238000011156 evaluation Methods 0.000 description 22
- 230000035699 permeability Effects 0.000 description 20
- 210000003491 skin Anatomy 0.000 description 19
- 239000008280 blood Substances 0.000 description 16
- 210000004369 blood Anatomy 0.000 description 16
- 239000002585 base Substances 0.000 description 14
- 239000000499 gel Substances 0.000 description 14
- 239000012790 adhesive layer Substances 0.000 description 13
- 210000004400 mucous membrane Anatomy 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 238000000034 method Methods 0.000 description 12
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 229960002897 heparin Drugs 0.000 description 9
- 229920000669 heparin Polymers 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 238000000576 coating method Methods 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 8
- AOMUHOFOVNGZAN-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)dodecanamide Chemical compound CCCCCCCCCCCC(=O)N(CCO)CCO AOMUHOFOVNGZAN-UHFFFAOYSA-N 0.000 description 7
- 238000009792 diffusion process Methods 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- 108010010803 Gelatin Proteins 0.000 description 6
- 241000283977 Oryctolagus Species 0.000 description 6
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 6
- 239000008273 gelatin Substances 0.000 description 6
- 229920000159 gelatin Polymers 0.000 description 6
- 235000019322 gelatine Nutrition 0.000 description 6
- 235000011852 gelatine desserts Nutrition 0.000 description 6
- 239000010410 layer Substances 0.000 description 6
- 210000000434 stratum corneum Anatomy 0.000 description 6
- 229920003169 water-soluble polymer Polymers 0.000 description 6
- 241000283973 Oryctolagus cuniculus Species 0.000 description 5
- 229920002125 Sokalan® Polymers 0.000 description 5
- 230000037374 absorbed through the skin Effects 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 229960001193 diclofenac sodium Drugs 0.000 description 5
- 238000000338 in vitro Methods 0.000 description 5
- 229940031957 lauric acid diethanolamide Drugs 0.000 description 5
- 210000002200 mouth mucosa Anatomy 0.000 description 5
- 239000005020 polyethylene terephthalate Substances 0.000 description 5
- 229920000139 polyethylene terephthalate Polymers 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- 229920005989 resin Polymers 0.000 description 5
- 239000011347 resin Substances 0.000 description 5
- JGMJQSFLQWGYMQ-UHFFFAOYSA-M sodium;2,6-dichloro-n-phenylaniline;acetate Chemical compound [Na+].CC([O-])=O.ClC1=CC=CC(Cl)=C1NC1=CC=CC=C1 JGMJQSFLQWGYMQ-UHFFFAOYSA-M 0.000 description 5
- 210000003462 vein Anatomy 0.000 description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 4
- 239000004698 Polyethylene Substances 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 229960000905 indomethacin Drugs 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Natural products OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 229920000573 polyethylene Polymers 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 238000010998 test method Methods 0.000 description 4
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 4
- 229920002554 vinyl polymer Polymers 0.000 description 4
- GOXQRTZXKQZDDN-UHFFFAOYSA-N 2-Ethylhexyl acrylate Chemical compound CCCCC(CC)COC(=O)C=C GOXQRTZXKQZDDN-UHFFFAOYSA-N 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 3
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 239000005639 Lauric acid Substances 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- CQEYYJKEWSMYFG-UHFFFAOYSA-N butyl acrylate Chemical compound CCCCOC(=O)C=C CQEYYJKEWSMYFG-UHFFFAOYSA-N 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 3
- 239000011976 maleic acid Substances 0.000 description 3
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 3
- 229920000058 polyacrylate Polymers 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- 239000011118 polyvinyl acetate Substances 0.000 description 3
- 229920002689 polyvinyl acetate Polymers 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 229920002050 silicone resin Polymers 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 2
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- 239000005995 Aluminium silicate Substances 0.000 description 2
- 229920000945 Amylopectin Polymers 0.000 description 2
- 241000416162 Astragalus gummifer Species 0.000 description 2
- SOGAXMICEFXMKE-UHFFFAOYSA-N Butylmethacrylate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 2
- 239000001856 Ethyl cellulose Substances 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 208000018522 Gastrointestinal disease Diseases 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- 244000043261 Hevea brasiliensis Species 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 2
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 2
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 229920001615 Tragacanth Polymers 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 239000000205 acacia gum Substances 0.000 description 2
- 150000003926 acrylamides Chemical class 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 235000012211 aluminium silicate Nutrition 0.000 description 2
- 125000003368 amide group Chemical group 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- VIROVYVQCGLCII-UHFFFAOYSA-N amobarbital Chemical compound CC(C)CCC1(CC)C(=O)NC(=O)NC1=O VIROVYVQCGLCII-UHFFFAOYSA-N 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 229940124599 anti-inflammatory drug Drugs 0.000 description 2
- 239000003416 antiarrhythmic agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 229940125715 antihistaminic agent Drugs 0.000 description 2
- 239000000739 antihistaminic agent Substances 0.000 description 2
- 229940030600 antihypertensive agent Drugs 0.000 description 2
- 239000002220 antihypertensive agent Substances 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 210000000436 anus Anatomy 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 2
- 235000014121 butter Nutrition 0.000 description 2
- 235000001046 cacaotero Nutrition 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- ALEXXDVDDISNDU-JZYPGELDSA-N cortisol 21-acetate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)C)(O)[C@@]1(C)C[C@@H]2O ALEXXDVDDISNDU-JZYPGELDSA-N 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 2
- 229940031578 diisopropyl adipate Drugs 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 229940030606 diuretics Drugs 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 235000019325 ethyl cellulose Nutrition 0.000 description 2
- 229920001249 ethyl cellulose Polymers 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 150000002430 hydrocarbons Chemical group 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 229960001067 hydrocortisone acetate Drugs 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 229960000201 isosorbide dinitrate Drugs 0.000 description 2
- MOYKHGMNXAOIAT-JGWLITMVSA-N isosorbide dinitrate Chemical compound [O-][N+](=O)O[C@H]1CO[C@@H]2[C@H](O[N+](=O)[O-])CO[C@@H]21 MOYKHGMNXAOIAT-JGWLITMVSA-N 0.000 description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 2
- 229960000991 ketoprofen Drugs 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 239000003589 local anesthetic agent Substances 0.000 description 2
- 229960005015 local anesthetics Drugs 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000007721 medicinal effect Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- BPXGKRUSMCVZAF-UHFFFAOYSA-N n,n-bis(2-hydroxyethyl)decanamide Chemical compound CCCCCCCCCC(=O)N(CCO)CCO BPXGKRUSMCVZAF-UHFFFAOYSA-N 0.000 description 2
- 229920003052 natural elastomer Polymers 0.000 description 2
- 229920001194 natural rubber Polymers 0.000 description 2
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 2
- 239000004745 nonwoven fabric Substances 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 239000011505 plaster Substances 0.000 description 2
- 229920001195 polyisoprene Polymers 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 2
- 229940068968 polysorbate 80 Drugs 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 239000004089 psychotropic agent Substances 0.000 description 2
- LOUPRKONTZGTKE-LHHVKLHASA-N quinidine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@H]2[C@@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-LHHVKLHASA-N 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 229930195734 saturated hydrocarbon Natural products 0.000 description 2
- 235000010413 sodium alginate Nutrition 0.000 description 2
- 239000000661 sodium alginate Substances 0.000 description 2
- 229940005550 sodium alginate Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- 150000003505 terpenes Chemical class 0.000 description 2
- 235000007586 terpenes Nutrition 0.000 description 2
- 229940124549 vasodilator Drugs 0.000 description 2
- 239000003071 vasodilator agent Substances 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- KQIXMZWXFFHRAQ-UHFFFAOYSA-N 1-(2-hydroxybutylamino)butan-2-ol Chemical compound CCC(O)CNCC(O)CC KQIXMZWXFFHRAQ-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- CJDRUOGAGYHKKD-RQBLFBSQSA-N 1pon08459r Chemical compound CN([C@H]1[C@@]2(C[C@@]3([H])[C@@H]([C@@H](O)N42)CC)[H])C2=CC=CC=C2[C@]11C[C@@]4([H])[C@H]3[C@H]1O CJDRUOGAGYHKKD-RQBLFBSQSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- RSNDTPFSMDVWCS-UHFFFAOYSA-N 2-(butoxymethyl)prop-2-enamide Chemical compound CCCCOCC(=C)C(N)=O RSNDTPFSMDVWCS-UHFFFAOYSA-N 0.000 description 1
- XCESYZPOWKEXHF-UHFFFAOYSA-N 2-(ethoxymethyl)prop-2-enamide Chemical compound CCOCC(=C)C(N)=O XCESYZPOWKEXHF-UHFFFAOYSA-N 0.000 description 1
- SPCKHVPPRJWQRZ-UHFFFAOYSA-N 2-benzhydryloxy-n,n-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 SPCKHVPPRJWQRZ-UHFFFAOYSA-N 0.000 description 1
- WDQMWEYDKDCEHT-UHFFFAOYSA-N 2-ethylhexyl 2-methylprop-2-enoate Chemical compound CCCCC(CC)COC(=O)C(C)=C WDQMWEYDKDCEHT-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- RUMACXVDVNRZJZ-UHFFFAOYSA-N 2-methylpropyl 2-methylprop-2-enoate Chemical compound CC(C)COC(=O)C(C)=C RUMACXVDVNRZJZ-UHFFFAOYSA-N 0.000 description 1
- CFVWNXQPGQOHRJ-UHFFFAOYSA-N 2-methylpropyl prop-2-enoate Chemical compound CC(C)COC(=O)C=C CFVWNXQPGQOHRJ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- PYSRRFNXTXNWCD-UHFFFAOYSA-N 3-(2-phenylethenyl)furan-2,5-dione Chemical compound O=C1OC(=O)C(C=CC=2C=CC=CC=2)=C1 PYSRRFNXTXNWCD-UHFFFAOYSA-N 0.000 description 1
- UVRCNEIYXSRHNT-UHFFFAOYSA-N 3-ethylpent-2-enamide Chemical compound CCC(CC)=CC(N)=O UVRCNEIYXSRHNT-UHFFFAOYSA-N 0.000 description 1
- WHNPOQXWAMXPTA-UHFFFAOYSA-N 3-methylbut-2-enamide Chemical compound CC(C)=CC(N)=O WHNPOQXWAMXPTA-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- JTHZUSWLNCPZLX-UHFFFAOYSA-N 6-fluoro-3-methyl-2h-indazole Chemical compound FC1=CC=C2C(C)=NNC2=C1 JTHZUSWLNCPZLX-UHFFFAOYSA-N 0.000 description 1
- NQSLZEHVGKWKAY-UHFFFAOYSA-N 6-methylheptyl 2-methylprop-2-enoate Chemical compound CC(C)CCCCCOC(=O)C(C)=C NQSLZEHVGKWKAY-UHFFFAOYSA-N 0.000 description 1
- DXPPIEDUBFUSEZ-UHFFFAOYSA-N 6-methylheptyl prop-2-enoate Chemical compound CC(C)CCCCCOC(=O)C=C DXPPIEDUBFUSEZ-UHFFFAOYSA-N 0.000 description 1
- VHRSUDSXCMQTMA-PJHHCJLFSA-N 6alpha-methylprednisolone Chemical compound C([C@@]12C)=CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C)[C@@](O)(C(=O)CO)CC[C@H]21 VHRSUDSXCMQTMA-PJHHCJLFSA-N 0.000 description 1
- COCLLEMEIJQBAG-UHFFFAOYSA-N 8-methylnonyl 2-methylprop-2-enoate Chemical compound CC(C)CCCCCCCOC(=O)C(C)=C COCLLEMEIJQBAG-UHFFFAOYSA-N 0.000 description 1
- LVGFPWDANALGOY-UHFFFAOYSA-N 8-methylnonyl prop-2-enoate Chemical compound CC(C)CCCCCCCOC(=O)C=C LVGFPWDANALGOY-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 229930000680 A04AD01 - Scopolamine Natural products 0.000 description 1
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- RNIHAPSVIGPAFF-UHFFFAOYSA-N Acrylamide-acrylic acid resin Chemical compound NC(=O)C=C.OC(=O)C=C RNIHAPSVIGPAFF-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 229920000623 Cellulose acetate phthalate Polymers 0.000 description 1
- 229920001412 Chicle Polymers 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- GJSURZIOUXUGAL-UHFFFAOYSA-N Clonidine Chemical compound ClC1=CC=CC(Cl)=C1NC1=NCCN1 GJSURZIOUXUGAL-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- HHJIUUAMYGBVSD-YTFFSALGSA-N Diflucortolone valerate Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@H](C(=O)COC(=O)CCCC)[C@@]2(C)C[C@@H]1O HHJIUUAMYGBVSD-YTFFSALGSA-N 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- WJOHZNCJWYWUJD-IUGZLZTKSA-N Fluocinonide Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)COC(=O)C)[C@@]2(C)C[C@@H]1O WJOHZNCJWYWUJD-IUGZLZTKSA-N 0.000 description 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- CJDRUOGAGYHKKD-UHFFFAOYSA-N Iso-ajmalin Natural products CN1C2=CC=CC=C2C2(C(C34)O)C1C1CC3C(CC)C(O)N1C4C2 CJDRUOGAGYHKKD-UHFFFAOYSA-N 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 240000001794 Manilkara zapota Species 0.000 description 1
- 235000011339 Manilkara zapota Nutrition 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 1
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- 239000005643 Pelargonic acid Substances 0.000 description 1
- TZRXHJWUDPFEEY-UHFFFAOYSA-N Pentaerythritol Tetranitrate Chemical compound [O-][N+](=O)OCC(CO[N+]([O-])=O)(CO[N+]([O-])=O)CO[N+]([O-])=O TZRXHJWUDPFEEY-UHFFFAOYSA-N 0.000 description 1
- 239000000026 Pentaerythritol tetranitrate Substances 0.000 description 1
- LGRFSURHDFAFJT-UHFFFAOYSA-N Phthalic anhydride Natural products C1=CC=C2C(=O)OC(=O)C2=C1 LGRFSURHDFAFJT-UHFFFAOYSA-N 0.000 description 1
- 229920012485 Plasticized Polyvinyl chloride Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920000805 Polyaspartic acid Polymers 0.000 description 1
- 239000005062 Polybutadiene Substances 0.000 description 1
- 108010020346 Polyglutamic Acid Proteins 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 244000061121 Rauvolfia serpentina Species 0.000 description 1
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 1
- 229920000147 Styrene maleic anhydride Polymers 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- WFWLQNSHRPWKFK-UHFFFAOYSA-N Tegafur Chemical compound O=C1NC(=O)C(F)=CN1C1OCCC1 WFWLQNSHRPWKFK-UHFFFAOYSA-N 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 1
- YWXYYJSYQOXTPL-JGWLITMVSA-N [(3r,3ar,6s,6as)-3-hydroxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl] nitrate Chemical compound [O-][N+](=O)O[C@H]1CO[C@@H]2[C@H](O)CO[C@@H]21 YWXYYJSYQOXTPL-JGWLITMVSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical class OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 229960004332 ajmaline Drugs 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- XYLMUPLGERFSHI-UHFFFAOYSA-N alpha-Methylstyrene Chemical compound CC(=C)C1=CC=CC=C1 XYLMUPLGERFSHI-UHFFFAOYSA-N 0.000 description 1
- 229960002213 alprenolol Drugs 0.000 description 1
- PAZJSJFMUHDSTF-UHFFFAOYSA-N alprenolol Chemical compound CC(C)NCC(O)COC1=CC=CC=C1CC=C PAZJSJFMUHDSTF-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 150000001408 amides Chemical group 0.000 description 1
- 229960001301 amobarbital Drugs 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- 235000012216 bentonite Nutrition 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960005274 benzocaine Drugs 0.000 description 1
- 229960004648 betamethasone acetate Drugs 0.000 description 1
- AKUJBENLRBOFTD-QZIXMDIESA-N betamethasone acetate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(C)=O)(O)[C@@]1(C)C[C@@H]2O AKUJBENLRBOFTD-QZIXMDIESA-N 0.000 description 1
- ZCNCBFKBQRZZFC-UHFFFAOYSA-N bis(2-hydroxyethyl)azanium;decanoate Chemical compound OCCNCCO.CCCCCCCCCC(O)=O ZCNCBFKBQRZZFC-UHFFFAOYSA-N 0.000 description 1
- YKHDBTDLVBKFDZ-UHFFFAOYSA-N bis(2-hydroxyethyl)azanium;octanoate Chemical compound OCCNCCO.CCCCCCCC(O)=O YKHDBTDLVBKFDZ-UHFFFAOYSA-N 0.000 description 1
- FUQCJMSCGSVFNQ-UHFFFAOYSA-N bis(2-hydroxyethyl)azanium;tetradecanoate Chemical compound OCCNCCO.CCCCCCCCCCCCCC(O)=O FUQCJMSCGSVFNQ-UHFFFAOYSA-N 0.000 description 1
- JHIWVOJDXOSYLW-UHFFFAOYSA-N butyl 2,2-difluorocyclopropane-1-carboxylate Chemical compound CCCCOC(=O)C1CC1(F)F JHIWVOJDXOSYLW-UHFFFAOYSA-N 0.000 description 1
- UTOVMEACOLCUCK-PLNGDYQASA-N butyl maleate Chemical compound CCCCOC(=O)\C=C/C(O)=O UTOVMEACOLCUCK-PLNGDYQASA-N 0.000 description 1
- CNYFJCCVJNARLE-UHFFFAOYSA-L calcium;2-sulfanylacetic acid;2-sulfidoacetate Chemical compound [Ca+2].[O-]C(=O)CS.[O-]C(=O)CS CNYFJCCVJNARLE-UHFFFAOYSA-L 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 229940081734 cellulose acetate phthalate Drugs 0.000 description 1
- 229920006184 cellulose methylcellulose Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 1
- 229960004703 clobetasol propionate Drugs 0.000 description 1
- CBGUOGMQLZIXBE-XGQKBEPLSA-N clobetasol propionate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CCl)(OC(=O)CC)[C@@]1(C)C[C@@H]2O CBGUOGMQLZIXBE-XGQKBEPLSA-N 0.000 description 1
- 229960002896 clonidine Drugs 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- DNTGGZPQPQTDQF-XBXARRHUSA-N crotamiton Chemical compound C/C=C/C(=O)N(CC)C1=CC=CC=C1C DNTGGZPQPQTDQF-XBXARRHUSA-N 0.000 description 1
- 229960003338 crotamiton Drugs 0.000 description 1
- LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 description 1
- ZPMVNZLARAEGHB-UHFFFAOYSA-N cyproheptadine hydrochloride (anhydrous) Chemical compound Cl.C1CN(C)CCC1=C1C2=CC=CC=C2C=CC2=CC=CC=C21 ZPMVNZLARAEGHB-UHFFFAOYSA-N 0.000 description 1
- GTBGXKPAKVYEKJ-UHFFFAOYSA-N decyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCOC(=O)C(C)=C GTBGXKPAKVYEKJ-UHFFFAOYSA-N 0.000 description 1
- FWLDHHJLVGRRHD-UHFFFAOYSA-N decyl prop-2-enoate Chemical compound CCCCCCCCCCOC(=O)C=C FWLDHHJLVGRRHD-UHFFFAOYSA-N 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- LVTYICIALWPMFW-UHFFFAOYSA-N diisopropanolamine Chemical compound CC(O)CNCC(C)O LVTYICIALWPMFW-UHFFFAOYSA-N 0.000 description 1
- 229940043276 diisopropanolamine Drugs 0.000 description 1
- HSUGRBWQSSZJOP-RTWAWAEBSA-N diltiazem Chemical compound C1=CC(OC)=CC=C1[C@H]1[C@@H](OC(C)=O)C(=O)N(CCN(C)C)C2=CC=CC=C2S1 HSUGRBWQSSZJOP-RTWAWAEBSA-N 0.000 description 1
- 229960004166 diltiazem Drugs 0.000 description 1
- HOSXICNCYBUYAW-UHFFFAOYSA-N dimethylamino prop-2-enoate Chemical compound CN(C)OC(=O)C=C HOSXICNCYBUYAW-UHFFFAOYSA-N 0.000 description 1
- 229960000520 diphenhydramine Drugs 0.000 description 1
- IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 description 1
- 229960002768 dipyridamole Drugs 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical class CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000001227 electron beam curing Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 description 1
- 235000010944 ethyl methyl cellulose Nutrition 0.000 description 1
- 239000001761 ethyl methyl cellulose Substances 0.000 description 1
- 239000005038 ethylene vinyl acetate Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229960001395 fenbufen Drugs 0.000 description 1
- ZPAKPRAICRBAOD-UHFFFAOYSA-N fenbufen Chemical compound C1=CC(C(=O)CCC(=O)O)=CC=C1C1=CC=CC=C1 ZPAKPRAICRBAOD-UHFFFAOYSA-N 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- LPEPZBJOKDYZAD-UHFFFAOYSA-N flufenamic acid Chemical compound OC(=O)C1=CC=CC=C1NC1=CC=CC(C(F)(F)F)=C1 LPEPZBJOKDYZAD-UHFFFAOYSA-N 0.000 description 1
- 229960004369 flufenamic acid Drugs 0.000 description 1
- 229960001347 fluocinolone acetonide Drugs 0.000 description 1
- FEBLZLNTKCEFIT-VSXGLTOVSA-N fluocinolone acetonide Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O FEBLZLNTKCEFIT-VSXGLTOVSA-N 0.000 description 1
- 229960000785 fluocinonide Drugs 0.000 description 1
- 229960002949 fluorouracil Drugs 0.000 description 1
- 229960002390 flurbiprofen Drugs 0.000 description 1
- SYTBZMRGLBWNTM-UHFFFAOYSA-N flurbiprofen Chemical compound FC1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-UHFFFAOYSA-N 0.000 description 1
- 210000003194 forelimb Anatomy 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 229920000578 graft copolymer Polymers 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- LNMQRPPRQDGUDR-UHFFFAOYSA-N hexyl prop-2-enoate Chemical compound CCCCCCOC(=O)C=C LNMQRPPRQDGUDR-UHFFFAOYSA-N 0.000 description 1
- 229940125697 hormonal agent Drugs 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 238000007757 hot melt coating Methods 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 229920013821 hydroxy alkyl cellulose Polymers 0.000 description 1
- 239000001341 hydroxy propyl starch Substances 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 235000013828 hydroxypropyl starch Nutrition 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 239000011256 inorganic filler Substances 0.000 description 1
- 229910003475 inorganic filler Inorganic materials 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- 239000000644 isotonic solution Substances 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- PBOSTUDLECTMNL-UHFFFAOYSA-N lauryl acrylate Chemical compound CCCCCCCCCCCCOC(=O)C=C PBOSTUDLECTMNL-UHFFFAOYSA-N 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229960004584 methylprednisolone Drugs 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 229960004857 mitomycin Drugs 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- FZQAYFWUOCXLKJ-UHFFFAOYSA-N n,n-bis(2-hydroxyethyl)octanamide Chemical compound CCCCCCCC(=O)N(CCO)CCO FZQAYFWUOCXLKJ-UHFFFAOYSA-N 0.000 description 1
- SKDZEPBJPGSFHS-UHFFFAOYSA-N n,n-bis(2-hydroxyethyl)tetradecanamide Chemical compound CCCCCCCCCCCCCC(=O)N(CCO)CCO SKDZEPBJPGSFHS-UHFFFAOYSA-N 0.000 description 1
- 229960002009 naproxen Drugs 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
- 229940097496 nasal spray Drugs 0.000 description 1
- 239000007922 nasal spray Substances 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- HMZGPNHSPWNGEP-UHFFFAOYSA-N octadecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)C(C)=C HMZGPNHSPWNGEP-UHFFFAOYSA-N 0.000 description 1
- KSCKTBJJRVPGKM-UHFFFAOYSA-N octan-1-olate;titanium(4+) Chemical compound [Ti+4].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-] KSCKTBJJRVPGKM-UHFFFAOYSA-N 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 229940065472 octyl acrylate Drugs 0.000 description 1
- ANISOHQJBAQUQP-UHFFFAOYSA-N octyl prop-2-enoate Chemical compound CCCCCCCCOC(=O)C=C ANISOHQJBAQUQP-UHFFFAOYSA-N 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229960004321 pentaerithrityl tetranitrate Drugs 0.000 description 1
- 239000000813 peptide hormone Substances 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- CHOBRHHOYQKCOU-UHFFFAOYSA-N phenbenzamine Chemical compound C=1C=CC=CC=1N(CCN(C)C)CC1=CC=CC=C1 CHOBRHHOYQKCOU-UHFFFAOYSA-N 0.000 description 1
- 229950003863 phenbenzamine Drugs 0.000 description 1
- DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 description 1
- 229960002695 phenobarbital Drugs 0.000 description 1
- 239000005011 phenolic resin Substances 0.000 description 1
- 229960002895 phenylbutazone Drugs 0.000 description 1
- VYMDGNCVAMGZFE-UHFFFAOYSA-N phenylbutazonum Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 VYMDGNCVAMGZFE-UHFFFAOYSA-N 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- PHUTUTUABXHXLW-UHFFFAOYSA-N pindolol Chemical compound CC(C)NCC(O)COC1=CC=CC2=NC=C[C]12 PHUTUTUABXHXLW-UHFFFAOYSA-N 0.000 description 1
- 229960002508 pindolol Drugs 0.000 description 1
- 229960002702 piroxicam Drugs 0.000 description 1
- QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 108010064470 polyaspartate Proteins 0.000 description 1
- 229920002857 polybutadiene Polymers 0.000 description 1
- 229920001083 polybutene Polymers 0.000 description 1
- 229920002643 polyglutamic acid Polymers 0.000 description 1
- 150000003097 polyterpenes Chemical class 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920001289 polyvinyl ether Polymers 0.000 description 1
- 239000005033 polyvinylidene chloride Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 229960005205 prednisolone Drugs 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- AQHHHDLHHXJYJD-UHFFFAOYSA-N propranolol Chemical compound C1=CC=C2C(OCC(O)CNC(C)C)=CC=CC2=C1 AQHHHDLHHXJYJD-UHFFFAOYSA-N 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 229940001470 psychoactive drug Drugs 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 229960001404 quinidine Drugs 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 1
- 229960002646 scopolamine Drugs 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 231100000245 skin permeability Toxicity 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- 229940032147 starch Drugs 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229920003048 styrene butadiene rubber Polymers 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 229960000894 sulindac Drugs 0.000 description 1
- MLKXDPUZXIRXEP-MFOYZWKCSA-N sulindac Chemical compound CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(S(C)=O)C=C1 MLKXDPUZXIRXEP-MFOYZWKCSA-N 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 229960002372 tetracaine Drugs 0.000 description 1
- GKCBAIGFKIBETG-UHFFFAOYSA-N tetracaine Chemical compound CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 GKCBAIGFKIBETG-UHFFFAOYSA-N 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical class CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 239000003451 thiazide diuretic agent Substances 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 235000010215 titanium dioxide Nutrition 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 1
- LDHQCZJRKDOVOX-UHFFFAOYSA-N trans-crotonic acid Natural products CC=CC(O)=O LDHQCZJRKDOVOX-UHFFFAOYSA-N 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- 229960002117 triamcinolone acetonide Drugs 0.000 description 1
- YNDXUCZADRHECN-JNQJZLCISA-N triamcinolone acetonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O YNDXUCZADRHECN-JNQJZLCISA-N 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 229920001567 vinyl ester resin Polymers 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 239000004034 viscosity adjusting agent Substances 0.000 description 1
- 229920003176 water-insoluble polymer Polymers 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 235000014692 zinc oxide Nutrition 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Description
ïŒç£æ¥äžã®å©çšåéïŒ
æ¬çºæã¯è¬ç©ãå«æãããããå€ãããŒã補å€
ãªã©ã®çµç®æäžåœ¢è£œå€ããã³ïŒãŸãã¯å£è å€ãç¹
çŒå€ã®ãªã©ã®çµç²èæäžåœ¢è£œå€ã«é¢ãããæ¬çºæ
ã¯ãç¹ã«ã該è¬ç©ã®åžåæ§ãé«ããçµç®ã»çµç²è
補å€ã«é¢ããã ïŒåŸæ¥ã®æè¡ïŒ å šèº«ãããã¯å±éšã§ã®è¬å¹ãåŸãããã«ãçµç®
æäžåœ¢è£œå€ããã³ïŒãŸãã¯çµç²èæäžåœ¢è£œå€ãçš
ããè¬ç©ïŒæŽç掻æ§ç©è³ªïŒãç®èãŸãã¯ç²èãä»
ããŠåžåãããããšãè¡ãããŠããããã®çµç®ã»
çµç²èæäžæ³ã¯ãåŸæ¥ã®çµå£æäžæ³ã«æ¯ã¹ãŠå©ç¹
ãå€ããäŸãã°ãè¬ç©ãçµå£æäžãããšãè žã§åž
åãããè¬ç©ã¯èèãžåŸªç°ããŠä»£è¬ãåããã
ãããã®è¬å¹ãçºæ®ããåã«ããªãã®éãå解ã
ããŠããŸããããã«å¯ŸããŠãçµç®ã»çµç²èæäžæ³
ã§ã¯ãåžåãããè¬ç©ã¯äœå ã®åå埪ç°æã«èè
ãééããªãããã®ãããèèã§ã®ä»£è¬ã«ããè¬
å¹ãå€§å¹ ã«æžãããšããããšããªããéã¹ããã€
ãç³»æççå€ãçµå£æäžãããšèè žé害ãçãã
ããããçµç®ã»çµç²èæäžã§ã¯ãã®ãããªèè žé
害ãçãã«ãããè¬ç©ã®åžåæ§ãã³ã³ãããŒã«ã
ãã°ãè¬ç©ãçæéã«å€§éã«åžåãããããã«èµ·
ããå¯äœçšã軜æžããããšãå¯èœãšãªããé·æé
ã«ãããäžå®ã®è¡äžæ¿åºŠãç¶æã§ããã°è¬ç©ãšæ
äžåæ°ãæžããããšãã§ããã ããããçµç®ã»çµç²è補å€ãçšããŠè¬ç©ãæäž
ããŠãã該è¬ç©ãç®èãç²èãééãã«ããçäœ
å©çšçïŒãã€ãªã¢ãã€ã©ããªãã€ïŒãäœããªãå Ž
åãå€ããç¹ã«ãç®èè¡šé¢ã«ã¯è§è³ªå±€ãååšãã
ãã®è§è³ªå±€ã¯äœå ãžç°ç©ãäŸµå ¥ããã®ãé²ãããª
ã¢ãŒæ©èœãæãããããè¬çå¹æãçºæ®ãããã«
å åãªéã®è¬ç©ãç®èãéããŠåžåãããªãå Žå
ãå€ãã è§è³ªå±€ã®ããªã€ãŒæ©èœã匱ããŠå åãªéã®è¬ç©
ãåžåãããã¹ãåžåä¿é²å€ãå«æããã補å€ã
補é ãããŠãããäŸãã°ãç¹éæ57â9714å·å ¬
å ±ãç¹å ¬æ58â43368å·å ¬å ±ãç¹éæ58â52216å·
å ¬å ±ãç¹éæ58â79918å·å ¬å ±ãç¹éæ60â13720
å·å ¬å ±ããã³ç¹éæ60â11431å·å ¬å ±ã«ã¯ãåžå
ä¿é²å€ãç²çå€å±€ã«å«æããã貌ä»å€ãªã©ãé瀺
ãããŠããã äžèšåžåä¿é²å€ã®ãã¡ãäŸãã°ããµãªãã«é žã
å°¿çŽ ããžã¡ãã«ã¹ã«ããã·ãã¯è§è³ªã溶解ããã
ãšãç¥ãããŠããããããããæ·»å ããŠãè¬ç©ã®
çµç®åžåæ§ã¯å¿ ãããè¯å¥œã§ã¯ãªãããããã¬ã³
ã°ãªã³ãŒã«ãã°ãªã»ãªã³ããããªãã³ã«ã«ãã³é ž
ãœãŒããªã©ã¯è§è³ªå±€ã«æ°Žåãä¿æããåŸãããè¬
ç©åžåä¿é²å¹æãã»ãšãã©èªããããªãããžã¡ã
ã«ã¹ã«ããã·ããªã©ã¯ãç®èãç²èãåºæ¿ããŠçŽ
æããã¶ããçãããããã¢ãžãã³é žãžã€ãœãã
ãã«ãªã©ã®ãžã«ã«ãã³é žãšã¹ãã«ãèèªé žãšã¹ã
ã«ãç²çå€å±€ã«å«æãããŠããŒã補å€ãšãããšã
ç²çå€ãšè¬ç©ãšã®çžæº¶æ§ãäœäžãããããè¬ç©ã
ç²çå€ããæåºãããããç²çæ§ãäœäžããããš
ããããããªã°ãªã³ãŒã«é žã«ã«ã·ãŠã ãªã©ã®ã€ãª
ãŠå«æååç©ã¯æªæ¯ã®åå ãšããªããäžèšååç©
ã®ä»ãããªã¹ãã³é žãšã¹ãã«ãã¢ãžãã³é žãšã¹ã
ã«ãã©ãŠãªã«ç¡«é žãšã¹ãã«ãããªãªã³ã·ãšãã¬ã³
ã¢ã«ãã«ãšãŒãã«ãªã©ãé瀺ãããŠãããããã
ãã®åžåä¿é²å€ãçšããŠãç®èãããã¯ç²èãé
ããŠã®è¬ç©ã®åžåéã¯å¿ ãããå åã§ãããšã¯ã
ããªãããã®ããã«ãè¬ç©ãå¹æçã«åžåããã
ãçµç®ã»çµç²è補å€ã¯ããŸã åŸãããªãã®ãçŸç¶
ã§ããã ïŒçºæã解決ããããšããåé¡ç¹ïŒ æ¬çºæã¯äžèšåŸæ¥ã®æ¬ ç¹ã解決ãããã®ã§ã
ãããã®ç®çãšãããšããã¯ãå«æããè¬ç©ãå¹
æçã«ç®èãç²èãéããŠåžåãããã補å€ãæ
äŸããããšã«ãããæ¬çºæã®ä»ã®ç®çã¯ãå«æã
ããè¬ç©ã®çµç®ã»çµç²èåžåæ§ãé«ãããã€ç®è
ãç²èã«å¯Ÿããåºæ¿æ§ããªãçäœã«å¯ŸããŠå®å šãª
åžåä¿é²å€ãå«æããçµç®ã»çµç²è補å€ãæäŸã
ãããšã«ãããæ¬çºæã®ããã«ä»ã®ç®çã¯ãåºå€
ã®æ§è³ªãå€åãããããšããªããããããè¬ç©ã
æåºããããšããªãããã€å«æãããè¬ç©ã®å€æ§
ãçããããšã®ãªãåžåä¿é²å€ãå«æããçµç®ã»
çµç²è補å€ãæäŸããããšã«ããã ïŒåé¡ç¹ã解決ããããã®ææ®µïŒ æ¬çºæã®çµç®ã»çµç²è補å€ã¯è¬ç©ããã³è©²è¬ç©
ã®åžåä¿é²å€ãå«æããçµç®ã»çµç²è補å€ã§ãã€
ãŠã該åžåä¿é²å€ãèèªé žãžã¢ã«ãããŒã«ã¢ãã
ã§ããã該èèªé žã®ççŽ æ°ãïŒã15ã§ããããã®
ããšã«ããäžèšç®çãéæãããã æ¬çºæã«çšããããåžåä¿é²å€ã¯ãäžèšåŒã§ç€º
ãããèèªé žãžã¢ã«ãããŒã«ã¢ããã§ããã ããã§R1ã¯ççŽ æ°ïŒã14ã®èèªæçåæ°ŽçŽ
åºïŒR2ã¯ççŽ æ°ïŒãïŒã®é£œåçåæ°ŽçŽ åºã§ããã äžèšååç©ã圢æãããèèªé žã¯ããã®ççŽ æ°
ãïŒã15ïŒçžåœããR1ã®ççŽ æ°ã¯ïŒã14ïŒã§ã
ãã奜ãŸããã¯10ã14ã§ãããççŽ æ°ãïŒã15ã®
ç¯å²ãå€ãããšè£œå€ã«å«æãããè¬ç©ã®åžåæ§ã
äœäžãããèèªé žãšããŠã¯ãã«ããªã«é žããã©ã«
ãŽã³é žãã«ããªã³é žãã©ãŠãªã³é žãããªã¹ãã³é ž
ãªã©ãæããããããããã¯ïŒçš®ä»¥äžæ··åããŠçš
ããããŠãããã ãããã®èèªé žã«ãžã¢ã«ãããŒã«ã¢ãã³HN
ïŒR2OHïŒ2ãçž®åããããšäžèšååç©ãåŸãããã
䜿çšããããžã¢ã«ãããŒã«ã¢ãã³ã®é£œåçåæ°ŽçŽ
åºR2ã¯ããã®ççŽ æ°ãïŒãïŒã§ãããççŽ æ°ã
ãã®ç¯å²å ã«ãããŠã¯ãççŽ æ°ã®å°ããã»ã©è¬ç©
ã®åžåæ§ã¯è¯å¥œã§ããããžã¢ã«ãããŒã«ã¢ãã³ãš
ããŠã¯ããžãšã¿ããŒã«ã¢ãã³ããžã€ãœãããããŒ
ã«ã¢ãã³ããžãã¿ããŒã«ã¢ãã³ããžãããµããŒã«
ã¢ãã³ãªã©ãããããã®ããã«ããŠåŸãããåžå
ä¿é²å€ã®ãã¡ã©ãŠãªã³é žãšãžãšã¿ããŒã«ã¢ãã³ã
çž®åããã©ãŠãªã³é žãžãšã¿ããŒã«ã¢ãããç¹ã«åª
ããå¹æã瀺ãã äžèšåžåä¿é²å€ã¯äžè¬ã«ã補å€äžã«0.01ã30é
éïŒ ã®å²åã§å«æãããããã®å²åã¯ãè»èå€ã
ã¯ãªãŒã 補å€ãåå€ãç¹çŒå€ãªã©ã§ã¯è£œå€å šäœã«
察ããå«æéã瀺ããäŸãã°ãããŒã補å€ããã
ãå€ãªã©ã®è²Œä»å€ã§ã¯ãè¬ç©å«æå±€ã«å¯Ÿããå«æ
éã瀺ããåŸè¿°ã®è¬ç©å«æéã«ã€ããŠãåæ§ã§ã
ããåžåä¿é²å€ã®éãéå°ãããšè¬ç©ã®åžåä¿é²
å¹æãåŸãããªããéå°ã§ãã€ãŠãè¬ç©ã®åžåæ§
ã¯ãã以äžåäžããªãã°ããããäŸãã°ããŒã補
å€ã§ã¯ç²çç©æ§ãäœäžããç²çå€ãšã®çžæº¶æ§ãæª
åããå Žåãããã 䜿çšãããè¬ç©ïŒçç掻æ§ç©è³ªïŒã¯çµç®ã»çµç²
èæäžã«ããçäœèãééããããã®ã§ããã°ã
ããç¹ã«éå®ãããªããäŸãã°ãéã¹ããã€ãç³»
æççå€ãã¹ããã€ãç³»æççå€ãè¡ç®¡æ¡åŒµå€ã
æäžæŽèå€ãæé«è¡å§å€ãæè «çå€ãå±æ麻é
å€ããã«ã¢ã³å€ãæãã¹ã¿ãã³å€ãæåè¡å€ãå©
å°¿å€ãå粟ç¥è¬ãç¡ç è¬ãæçç©è³ªãæããã
ãã éã¹ããã€ãç³»æççå€ãšããŠã¯ããµãªãã«
é žãã¢ã¹ããªã³ãã¢ã»ãã¢ããããšã³ããžã¯ãã
ãšããã¯ãããªãŠã ãã€ãããããšã³ãã¹ãªã³ã
ãã¯ãããããã»ã³ãã±ãããããšã³ããã«ããš
ãã é žãã€ããããã¯ãããšã³ãããšã³ãã¢ã«ã¯
ãããšããã¯ãããšãã«ãã¿ãŸã³ãã¡ããã é žã
ã€ã³ãã¡ã¿ã·ã³ããã³ãã¶ãã¯ããããã·ã«ã ã
ãã«ã«ãããããšã³ãªã©ãããã ã¹ããã€ãç³»æççå€ãšããŠã¯ããããã³ã«ã
ãŸã³ããã¬ãããŸãã³ããã«ãªã·ããã³ã¢ã»ãã
ãããã«ããã·ã³ã«ãããã¡ãã«ãã¬ãããŸã
ã³ãé ¢é žãããã³ã«ããŸã³ãããªã¢ã ã·ããã³ã¢
ã»ãããããããµã¡ã¿ãŸã³ãé ¢é žãã¿ã¡ãµãŸã³ã
åèé žãžãã«ã³ã«ããã³ãããããªã³é žã¯ããã¿
ãŸãŒã«ããã«ãªã·ããããªã©ãããã è¡ç®¡æ¡åŒµå€ãšããŠã¯ããžã«ãã¢ãŒã ããã©ãã
ã«ãåç¡é žãã³ã¿ãšãªã¹ãªãŒãã«ããžããªãã¢ãŒ
ã«ãç¡é žã€ãœãœã«ãããªã©ãããã æäžæŽèå€ãšããŠã¯ãããããããŒã«ããã³ã
ããŒã«ããããžã³ãã¢ãžããªã³ããã©ããªã³ãã¢
ã«ãã¬ãããŒã«ãªã©ããããæé«è¡å§å€ãšããŠ
ã¯ãã¯ãããžã³ãªã©ããããæè «çå€ãšããŠã¯ã
ïŒâãã«ãªããŠã©ã·ã«ãïŒâïŒïŒâããã©ããã
ããªã«ïŒâïŒâãã«ãªããŠã©ã·ã«ããã€ããã€ã·
ã³ïŒ£ãªã©ããããå±æ麻é å€ãšããŠã¯ããã³ãŸã«
ã€ã³ãããã«ã€ã³ããªãã«ã€ã³ãããã©ã«ã€ã³ãª
ã©ãããããã«ã¢ã³å€ãšããŠã¯ããšã¹ããã²ã³ã
ãšã¹ãã©ãžãªãŒã«ããã¹ãã¹ããã³ãããã²ã¹ã
ãã³ãªã©ã®ã¹ããã€ããã«ã¢ã³é¡ïŒã€ã³ã¹ãªã³ãª
ã©ã®ãããããã«ã¢ã³é¡ïŒããã¹ã¿ã°ã©ã³ãžã³ãª
ã©ããããæãã¹ã¿ãã³å€ãšããŠã¯ãã·ã¯ããã
ã¿ãžã³ãã€ããã¯ãã©ã€ãããžããšã³ããã©ã
ã³ãããšã³ãã³ã¶ãã³ãªã©ããããæåè¡è¬ãšã
ãŠã¯ãããªã³ãªã©ããå©å°¿å€ãšããŠã¯ãµã€ã¢ã¶ã€
ããªã©ããå粟ç¥å€ãšããŠã¯ã¹ã³ãã©ãã³ãã¯ã
ãã«ãããŒãŠãªã©ããããç¡ç è¬ãšããŠã¯ããšã
ãã«ãã¿ãŒã«ãã¢ã¢ãã«ãã¿ãŒã«ãªã©ãïŒæçç©
質ãšããŠã¯ããã©ãµã€ã¯ãªã³ãã¯ãã©ã ããšãã³
ãŒã«ãªã©ãããããããè¬ç©ã®é åéã¯ãè¬ç©ã®
çš®é¡ã補å€ã®äœ¿çšç®çãªã©ã«ããç°ãªãããé
åžžãè¬ç©ã¯è£œå€äžã«0.1ã30ééïŒ ã®å²åã§å«æ
ãããã ãããã®è¬ç©ãšäžèšåžåä¿é²å€ãšãå«æããæ¬
çºæã®çµç®ã»çµç²è補å€ã®ãã¡çµç®æäžå補å€ãš
ããŠã¯ãããŒã補å€ããããå€ããããå€ãè»è
å€ãã¯ãªãŒã 補å€ãªã©ããããçµç²èæäžå補å€
ãšããŠã¯ãåå€ãå£è å€ãç¹éŒ»å€ãç¹çŒå€ãªã©ã
ããã äžèšè£œå€ã®ãã¡ããŒã補å€ããããå€ã¯ãæ¯æ
äœã®çé¢ã«è¬ç©ãšåžåä¿é²å€ãšãå«æããç²çå€
å±€ã圢æãããŠãããããŒã補å€ããããå€ã®åº
å€ïŒç²çå€ïŒã¯è©²è£œå€ãåžžæž©ã§ç®èè¡šé¢ã«é·æé
åºå®ãããç²çåãããã°å åã§ãããç¹ã«éå®
ãããªããäŸãã°ã¢ã¯ãªã«ç³»ããŽã ç³»ãã·ãªã³ãŒ
ã³æš¹èç³»ãªã©ã®ç²çå€ãå©çšããåŸãéåžžãã¢ã¯
ãªã«ç³»ããã³ãŽã ç³»ã®ç²çå€ãçšããããã ã¢ã¯ãªã«ç³»ç²çå€ã§ã¯ããã®ç²çç©æ§ãªã©ã
ããç¹ã«ãççŽ æ°ïŒã18ã®èèªæã¢ã«ã³ãŒã«ãš
ïŒã¡ã¿ïŒã¢ã¯ãªã«é žãšããåŸãããïŒã¡ã¿ïŒã¢ã¯
ãªã«é žã¢ã«ãã«ãšã¹ãã«ã®ïŒå ±ïŒéåäœããã³ïŒ
ãŸãã¯äžèšïŒã¡ã¿ïŒã¢ã¯ãªã«é žã¢ã«ãã«ãšã¹ãã«
ãšãã®ä»ã®å®èœæ§ã¢ãããŒãšã®å ±éåäœã奜é©ã«
çšããããã äžèšïŒã¡ã¿ïŒã¢ã¯ãªã«é žãšã¹ãã«ãšããŠã¯ãã¢
ã¯ãªã«é žããã«ãã¢ã¯ãªã«é žã€ãœããã«ãã¢ã¯ãª
ã«é žããã·ã«ããã¢ã¯ãªã«é žãªã¯ãã«ãã¢ã¯ãªã«
é žïŒãšãã«ããã·ã«ãã¢ã¯ãªã«é žã€ãœãªã¯ãã«ã
ã¢ã¯ãªã«é žãã·ã«ãã¢ã¯ãªã«é žã€ãœãã·ã«ãã¢ã¯
ãªã«é žã©ãŠãªã«ãã¢ã¯ãªã«é žã¹ãã¢ãªã«ãã¡ã¿ã¯
ãªã«é žã¡ãã«ãã¡ã¿ã¯ãªã«é žãšãã«ãã¡ã¿ã¯ãªã«
é žããã«ãã¡ã¿ã¯ãªã«é žã€ãœããã«ãã¡ã¿ã¯ãªã«
é žïŒãšãã«ããã·ã«ãã¡ã¿ã¯ãªã«é žã€ãœãªã¯ã
ã«ãã¡ã¿ã¯ãªã«é žãã·ã«ãã¡ã¿ã¯ãªã«é žã€ãœãã·
ã«ãã¡ã¿ã¯ãªã«é žã©ãŠãªã«ãã¡ã¿ã¯ãªã«é žã¹ãã¢
ãªã«ãªã©ãããã äžèšå®èœæ§ã¢ãããŒã«ã¯ãæ°Žé žåºãæããã¢ã
ããŒãã«ã«ããã·ã«åºãæããã¢ãããŒãã¢ãã
åºãæããã¢ãããŒãã¢ããåºãæããã¢ãããŒ
ãªã©ãæãããããæ°Žé žåºãæããã¢ãããŒãšã
ãŠã¯ãïŒâããããã·ãšãã«ïŒã¡ã¿ïŒã¢ã¯ãªã¬ãŒ
ããããããã·ãããã«ïŒã¡ã¿ïŒã¢ã¯ãªã¬ãŒããª
ã©ã®ããããã·ã¢ã«ãã«ïŒã¡ã¿ïŒã¢ã¯ãªã¬ãŒãã
ãããã«ã«ããã·ã«åºãæããã¢ãããŒãšããŠ
ã¯ãã¢ã¯ãªã«é žãã¡ã¿ã¯ãªã«é žãªã©ã®Î±âβäžé£œ
åã«ã«ãã³é žïŒãã¬ã€ã³é žããã«ãªã©ã®ãã¬ã€ã³
é žã¢ãã¢ã«ãã«ãšã¹ãã«ïŒãã¬ã€ã³é žïŒããã«
é žïŒã¯ããã³é žãªã©ããããç¡æ°Žãã¬ã€ã³é žãã
ã¬ã€ã³é žãšåæ§ã®ïŒå ±ïŒéåæåãäžãããã¢ã
ãåºãæããã¢ãããŒãšããŠã¯ãã¢ã¯ãªã«ã¢ã
ãããžã¡ãã«ã¢ã¯ãªã«ã¢ããããžãšãã«ã¢ã¯ãªã«
ã¢ãããªã©ã®ã¢ã«ãã«ïŒã¡ã¿ïŒã¢ã¯ãªã«ã¢ããïŒ
ãããã·ã¡ãã«ã¢ã¯ãªã«ã¢ããããšããã·ã¡ãã«
ã¢ã¯ãªã«ã¢ãããªã©ã®ã¢ã«ãã«ãšãŒãã«ã¡ãããŒ
ã«ïŒã¡ã¿ïŒã¢ã¯ãªã«ã¢ãããªã©ããããã¢ããåº
ãæããã¢ãããŒãšããŠã¯ããžã¡ãã«ã¢ããã¢ã¯
ãªã¬ãŒããªã©ãããã äžèšä»¥å€ã®å ±éåæ§ã¢ãããŒãšããŠé ¢é žãã
ã«ãã¹ãã¬ã³ãαâã¡ãã«ã¹ãã¬ã³ãå¡©åãã
ã«ãã¢ã¯ãªãããªã«ããšãã¬ã³ããããã¬ã³ãã
ã¿ãžãšã³ãªã©ãæãããããããããå ±éåãã
ãŠããŠããããç²çå€äžïŒã¡ã¿ïŒã¢ã¯ãªã«é žã¢ã«
ãã«ãšã¹ãã«ãïŒå ±ïŒéåæåãšããŠ50ééïŒ ä»¥
äžå«æãããããšã奜ãŸããã ãŽã ç³»ç²çå€ãšããŠã¯ã倩ç¶ãŽã ãããªã€ãœã
ã¬ã³ãããªã€ãœããã¬ã³ãããªããã«ãšãŒãã«ã
ããªãŠã¬ã¿ã³ãããªãã¿ãžãšã³ãã¹ãã¬ã³âãã¿
ãžãšã³å ±éåäœãã¹ãã¬ã³âã€ãœãã¬ã³å ±éåäœ
ãªã©ãçšãããããã·ãªã³ãŒã³æš¹èç³»ç²çå€ãšã
ãŠã¯ãããªãªã«ã¬ãã·ãããµã³ãªã©ã®ã·ãªã³ãŒã³
ãŽã ãçšããããããããã®ã»ããããªé ¢é žãã
ã«ã倩ç¶ãã¯ã«ãªã©ãå©çšããããã äžèšç²çå€äžã«ã¯å¿ èŠã«å¿ããŠåçš®é åå€ãäŸ
ãã°ããžã³ç³»æš¹èãããªãã«ãã³æš¹èãã¯ããã³
âã€ã³ãã³æš¹èãç³æ²¹ç³»æš¹èããã«ãã³ããšããŒ
ã«æš¹èãªã©ã®ç²çæ§ä»äžå€ïŒæ¶²ç¶ããªããã³ãé±
æ²¹ã©ããªã³ã液ç¶ããªã€ãœãã¬ã³ã液ç¶ããªã¢ã¯
ãªã¬ãŒããªã©ã®å¯å¡å€ïŒå å¡«å€ïŒèåé²æ¢å€ïŒã
æ·»å ãããã ããŒã補å€ããããå€ãããã³åŸè¿°ã®ãããå€
ã®æ¯æäœãšããŠã¯ã貌ä»å€ã«éåžžå©çšãããæ¯æ
äœãçšããããããã®ãããªæ¯æäœã®çŽ æãšããŠ
ã¯ãé ¢é žã»ã«ããŒã¹ããšãã«ã»ã«ããŒã¹ãããªãš
ãã¬ã³ãã¬ãã¿ã¬ãŒããé ¢é žããã«âå¡©åããã«
å ±éåäœããã€ãã³ããšãã¬ã³âé ¢é žããã«å ±é
åäœãå¯å¡åããªå¡©åããã«ãããªãŠã¬ã¿ã³ãã
ãªãšãã¬ã³ãããªå¡©åãããªãã³ãã¢ã«ãããŠã
ãªã©ãããããããã¯ãäŸãã°ãåå±€ã®ã·ãŒã
ïŒãã€ã«ã ïŒãäºæ以äžã®ç©å±€ïŒã©ãããŒãïŒäœ
ãšããŠçšãããããã¢ã«ãããŠã 以å€ã®çŽ æã¯ç¹
åžãäžç¹åžãšããŠå©çšããŠãããã äžèšæ¯æäœè¡šé¢ã«è¬ç©ãšåžåä¿é²å€ãšãå«æã
ãè¬ç©å«æïŒç²çå€ïŒå±€ã圢æãããŠããŒã補å€
ããããå€ãåŸããããç²çå€å±€ã圢æããã«
ã¯ã溶å€å¡å·¥æ³ããããã¡ã«ãå¡å·¥æ³ãé»åç·ç¡¬
åãšãã«ãžãšã³å¡å·¥æ³ãªã©çš®ã ã®å¡å·¥æ³ãçšãã
ãããããªãã§ã溶å€å¡å·¥æ³ã奜é©ã«çšããã
ãã溶å€å¡å·¥æ³ã§ç²çå€å±€ã圢æããã«ã¯ãäŸã
ã°ãç²çå€ãé©åœãªæº¶åªã§çšéããããã«è¬ç©ã
åžåä¿é²å€ãããã«å¿ èŠã«å¿ããŠé åå€ãå ããŠ
åäžã«æ··åããåŸããã溶液ãæ¯æäœè¡šé¢ã«å¡
åžã»ä¹Ÿç¥ããã溶液ãçŽæ¥æ¯æäœè¡šé¢ã«å¡åžãã
ã«ã·ãªã³ãŒã³æš¹èãªã©ãã³ãŒãã€ã³ã°ããå¥é¢çŽ
äžã«å¡åžãã也ç¥åŸã«æ¯æäœã®å¯çãããŠãã
ãããã®ãããªå¥é¢çŽã¯ã䜿çšæãŸã§è²Œä»å€ã®ç²
çå€å±€è¡šé¢ãä¿è·ããããã«çšããããã溶å€å¡
å·¥æ³ä»¥å€ã®å¡å·¥æ³ã«ãããŠãç²çå€å±€åœ¢æåŸãç²
çå€å±€è¡šé¢ä¿è·ã®ããã«å¥é¢çŽãé ããããšãæš
奚ããããç²çå€å±€ã®åã¿ã䜿çšç®çã«ããç°ãª
ãããéåžžã30ã200ÎŒïœã§ããã80ÎŒïœãäžãŸã
ããšå¿ èŠéã®è¬ç©ãå«æããããšãã§ãããç²ç
æ§ãäžå åã§ããã200ÎŒïœãäžãŸãããšæ¯æäœ
ä»è¿ã®ç²çå€å±€ã«å«æãããè¬ç©ãå åã«æ¡æ£ã
ããè¬ç©æŸåºæ§ãäœäžããã ãããå€ãæ¯æäœã®çé¢ã«è¬ç©ãåžåä¿é²å€ã
å«æããè¬ç©å«æå±€ã圢æãããŠãããéåžžãã
ãŒã補å€ããããå€ã«æ¯ã¹ãŠç²çæ§ã«ä¹ãããã
çµåµèãªã©ã§ç®èè¡šé¢ãžåºå®ãããããããå€ã®
åºå€ã®äž»æåãšããŠã¯ãéåžžã氎溶æ§ã®ããªããŒ
ã䜿çšãããããã®ãããªããªããŒãšããŠã¯ãäŸ
ãã°ãã¢ã©ãã¢ã¬ã ããã©ã¬ã³ãã¬ã ãããŒã«ã¹
ãããŒã³ã¬ã ãã°ã¢ãŒã¬ã ããšã³ãŒã¬ã ãã«ã©ã€
ãŽã ãå¯å€©ããã³ãã³ãã«ã©ã²ãã³ãã¢ã«ã®ã³
é žãã¢ã«ã®ã³é žå¡©ïŒäŸãã°ã¢ã«ã®ã³é žãœãŒãïŒã
ã¢ã«ã®ã³é žãããã¬ã³ã°ãªã³ãŒã«ãããã¹ãã©
ã³ãããã¹ããªã³ãã¢ãããŒã¹ããŒã©ãã³ãã³ã©
ãŒã²ã³ããã«ã©ã³ããã¯ãã³ãã¢ãããã¯ãã³ã
ã¹ã¿ãŒããã¢ãããã¯ãã³ã»ãã°ãªã³ãŒã«é žãã
ãªãŠã ãããã³ãã¢ã«ããã³ãã«ãŒã€ã³ãããªã°
ã«ã¿ãã³é žãããªã¢ã¹ãã©ã®ã³é žãªã©ã®å€©ç¶ããª
ããŒïŒã¡ãã«ã»ã«ããŒã¹ããšãã«ã»ã«ããŒã¹ãã
ããã«ã»ã«ããŒã¹ããšãã«ã¡ãã«ã»ã«ããŒã¹ãã
ãããã·ã»ã«ããŒã¹ãããããã·ã¢ã«ãã«ã»ã«ã
ãŒã¹ãããããã·ãããã«ã¡ãã«ã»ã«ããŒã¹ãã
ãããã·ãããã«ã¹ã¿ãŒããã«ã«ããã·ã¡ãã«ã¹
ã¿ãŒããã¢ã«ã«ãªéå±ã«ã«ããã·ã¡ãã«ã»ã«ããŒ
ã¹ãã¢ã«ã«ãªéå±ã»ã«ããŒã¹ç¡«é žå¡©ãã»ã«ããŒã¹
ã¢ã»ããŒããã¿ã¬ãŒãããã³ãã³âã¢ã¯ãªã«é žã°
ã©ããéåäœãæ¶æ©ãŒã©ãã³ãç¡æ°Žãã¿ã«é žå€æ§
ãŒã©ãã³ãã³ãã¯é žå€æ§ãŒã©ãã³ãªã©ã®ååæã
ãªããŒïŒããªããã«ã¢ã«ã³ãŒã«ãããªããã«ãã
ãªãã³ãããªããã«ã¡ãã«ãšãŒãã«ãã¡ãã«ãã
ã«ãšã¹ãã«ãããªã¢ã¯ãªã«é žå¡©ïŒäŸãã°ããªã¢ã¯
ãªã«é žãœãŒãïŒãã«ã«ããã·ããã«ããªããŒãã
ãã«ãããªãã³âãªã¯ãªã«é žãšãã«å ±éåäœãã
ãã«ãããªãã³âã¹ãã¬ã³å ±éåäœãããã«ãã
ãªãã³âé ¢é žããã«å ±éåäœãããªããã«ã¢ã»ã
ãŒãâïŒã¡ã¿ïŒã¢ã¯ãªã«é žå ±éåäœãããªããã«
ã¢ã»ããŒãâã¯ããã³é žå ±éåäœãé ¢é žããã«â
ïŒã¡ã¿ïŒã¢ã¯ãªã«é žå ±éåäœãé ¢é žããã«âã¯ã
ãã³é žå ±éåäœãããªããã«ã¹ã«ãã³é žãããªã€
ã¿ã³ã³é žãããªããããã·ãšãã«ã¢ã¯ãªã¬ãŒãã
ããªã¢ã¯ãªã«ã¢ãããã¹ãã¬ã³âãã¬ã€é žç¡æ°Žç©
å ±éåäœããšãã¬ã³âãã¬ã€ã³é žç¡æ°Žç©å ±éå
äœãã¢ã¯ãªã«ã¢ããâã¢ã¯ãªã«é žå ±éåäœãªã©ã®
åæããªããŒãããã äžèšæ°Žæº¶æ§ããªããŒãæ°Žãè¬ç©ããã³åžåä¿é²
å€ãåäžã«æ··åãã氎溶æ§ããªããŒåã³æ°Žãããª
ãå«æ°Žåºå€ã«è¬ç©åã³åžåä¿é²å€ãå«æãããè¬
ç©å«æå±€ãåèšæ¯æäœè¡šé¢ã«åœ¢æããŠææã®ãã
ãå€ãåŸãããã åãäžèšæ°Žæº¶æ§ããªããŒä»¥å€ã®åèšã¢ã¯ãªã«ç³»
ããªããŒããŽã ç³»ããªããŒãã·ãªã³ã³ç³»ããªããŒ
çã®é氎溶æ§ããªããŒã«æ°Žãå«æãããŠå«æ°Žåºå€
ãæ§æããããã«è¬ç©åã³åžåä¿é²å€åã³å¿ èŠã«
å¿ã氎溶æ§ããªããŒãå ããŠè¬ç©å«æå±€ãšãªããŠ
ãããå€ãåŸãããšãå¯èœã§ããã å«æ°Žåºå€ã«å«æãããæ°Žã®éã¯åºå€ãè¬ç©ãã
ã³åžåä¿é²å€ãå«ã補å€ã®ïŒã90ééïŒ ãã奜ãŸ
ããã¯ïŒã90ééïŒ ã§ããããã®ããã«æ°Žãå«æ
ãããããšã«ãããå«æ°Žåºå€ãæ§æãããããã
ã¯åŸè¿°ããè»èå€ãã¯ãªãŒã 補å€ã®å Žåãåæ§ã§
ãããæ°Žãäžèšç¯å²ã§å«æããããšè¬ç©ã®åžåä¿
é²å€ã®å¹æãå€§å¹ ã«å¢åŒ·ããããæ°Žã®éãéå°ã§
ãããšè¬ç©ã®åžåä¿é²å€ãããŸã倧ãããªããã
ã€è£œå€ãç®èè¡šé¢ãžå¯çãããšãã«æ°Žåã®èžçºã«
ããå·æå¹æãåŸãããªããæ°Žã®éãéå°ã§ãã
ãšæµåæ§ã倧ãããªãã補å€ã®åœ¢ç¶ãä¿ã€ã®ãé£
ãããªãã äžèšè¬ç©å«æå±€ã«ã¯ããã«ãå€äŸ¡ã¢ã«ã³ãŒã«
ïŒäŸãã°ãã°ãªã»ãªã³ããããã¬ã³ã°ãªã³ãŒã«ïŒ
ãªã©ã®ä¿æ¹¿å€ïŒã«ãªãªã³ããã³ããã€ããäºé
è¯ãäºé žåãã¿ã³ãªã©ã®ç¡æ©å å¡«å€ïŒç²åºŠèª¿æŽ
å€ïŒæ¶æ©å€ïŒèåé²æ¢å€ïŒãªã©ãå«æããããŠã
ããã è»èå€ãã¯ãªãŒã 補å€ã®åºå€ã®äž»æåã«ã¯ãã
ããŠãæ²¹èãã©ããªã³ãçœè²ã¯ã»ãªã³ããã©ãã€
ã³ããã©ã¹ãããŒã¹ããŒã¬ã³50WïŒåååïŒãé«çŽ
èèªé žãé«çŽã¢ã«ã³ãŒã«ãä¹³åå€ããã¯ããŽãŒ
ã«ãã«ã«ããã·ããã«ããªããŒãªã©ãããããã
ãååç©ã«è¬ç©ãšåžåä¿é²å€ãšãæ··åãããŠè»è
å€ãã¯ãªãŒã 補å€ãåŸããããæ··åæã«ã¯ãå¿ èŠ
ã«å¿ããŠã¯ãã¿ããã³ãæµåãã©ãã€ã³ãããªã¹
ãã³é žã€ãœãããã«ãã»ãã·ã³é žãžãšãã«ãªã©ã®
è溶æ§æº¶è§£å€ïŒç²Ÿè£œæ°ŽïŒãšã¿ããŒã«ãå€äŸ¡ã¢ã«ã³
ãŒã«ïŒäŸãã°ã°ãªã»ãªã³ïŒãªã©ã®æ°Žæº¶æ§æº¶è§£å€ïŒ
PH調æŽå€ïŒãªã©ãæ·»å ãããã å£è å€ãç¹éŒ»å€ãç¹çŒå€ãè»èç¶ãã¯ãªãŒã ç¶
ã§ããå Žåã«ã¯ãäžèšè»èå€ãã¯ãªãŒã 補å€ã®åº
å€ãçšããããè»èå€ãã¯ãªãŒã å€ãšåæ§ã®æ¹æ³
ã§èª¿æŽãããã溶液ïŒæžæ¿æ¶²ïŒããŒãªãŒç¶ã§ãã
å Žåã«ã¯ãäŸãã°ããšã¿ããŒã«ã粟補氎ãã°ãªã³
ãŒã«é¡ã«è¬ç©ãåžåä¿é²å€ã溶解ãããã¯æžæ¿ã
ããŠææã®è£œå€ãåŸãããããã©ã¬ã³ããã¢ã©ã
ã¢ãŽã ãã¢ã«ã®ã³é žãããªãŠã ããŒã©ãã³ãã¡ã¿
ã«ã»ã«ããŒã¹ãã«ã«ããã·ã¡ãã«ã»ã«ããŒã¹
ïŒCMCïŒãªã©ã®æ°Žæº¶æ§ããªããŒãšæ°Žãšã®æ··å液ã«
è¬ç©ãåžåä¿é²å€ã溶解ãããã¯åæ£ãããå Žå
ããããå£è å€ã®ãã¡å£å€çšè²Œä»å€ãšããŠã¯ãã
ãŒã補å€ããããå€ããããå€ãšåã圢æ ã®è²Œä»
å€ãçšããããšãã§ãããäŸãã°ãåºå€ã«è¬ç©ãš
åžåä¿é²å€ãšãå ããŠè¬ç©å«æãã€ã«ã ã調補
ãããã®è¡šé¢ã«è¬ç©ãéããã®ãé²ãããã«éæ°Ž
溶æ§ãã€ã«ã ãç©å±€ããç©å±€äœãå©çšããããã åå€ã®åºå€ãšããŠã¯ã«ã«ãªèãããŒã æ²¹ãã€ã·
æ²¹ãåç»ã³ã³ãããæ²¹ãªã©ã®æ²¹èïŒã¯ã»ãªã³ãªã©
ã䜿çšããããäžèšåºå€ã«è¬ç©ãšåžåä¿é²å€ãšã
åäžã«æ··åããåå€æååšãçšããŠææã®åå€ã
調補ãããã ïŒäœçšïŒ æ¬çºæã®çµç®ã»çµç²è補å€ãç®èãããã¯ç²è
è¡šé¢ã«å¯çããããšå«æãããè¬ç©ã容æã«ç®è
ãããã¯ç²èãéããŠåžåãããããã®è©³çŽ°ãªæ©
æ§ã¯äžæã§ããããåžåä¿é²å€ãç®èãããã¯ç²
èã«äœ¿çšãããã®èçœè³ªãå€æ§ãããå«æ°Žçãäž
æãããŠè»åããããããšèããããããã®ã
ããéåžžãè¬ç©ãééãã«ããç®èè¡šé¢ã®è§è³ªå±€
ãè»åããŠå«æãããè¬ç©ã容æã«ç®èãéããŠ
åžåããããšèããããã å¿ èŠãªè¬ç©ãåŸãã®ã«å åãªéã®è¬ç©ã容æã«
åžåããããããåŸæ¥ã®ããã«å€§éã®è¬ç©ã補å€
äžã«å«æãããå¿ èŠããªããã€ãŸããè¬ç©ã®ãã€
ãªã¢ãã€ã©ããªãã€ãé«ãããã®ãããªçµç®ã»çµ
ç²èåžåä¿é²å¹æã¯åŸæ¥ã®åžåä¿é²å€ãçšãããš
ããããã¯ããã«é«ããããã«ãæ¬çºæã«çšãã
åžåä¿é²å€ã¯ç®èãç²èã«å¯Ÿããåºæ¿æ§ããªãå®
å šæ§ãé«ããå«æãããè¬ç©ãå€æ§ãããããšã
ãªããåºå€ãšã®çžæº¶æ§ã«ãåªãããè¬ç©ãšåºå€ãš
ã®çžæº¶æ§ã«å€åãäžããªãããã調補åŸã®è£œå€ã
ãè¬ç©ãæåºããããšããªããããŒã補å€ããã
ãå€ãšãããšãã«ã¯ãåžåä¿é²å€èªäœãç²çå€ã®
ç²çæ©èœãäœäžããããªã©ç²çå€ã®ç©æ§ã«æªåœ±é¿
ããããŒãããšããªãã ïŒå®æœäŸïŒ 以äžã«æ¬çºæãå®æœäŸã«ã€ããŠèª¬æããã å®æœäŸ ïŒ (A) 貌ä»å€ïŒããŒã補å€ïŒã®èª¿è£œïŒã¢ã¯ãªã«é žïŒ
ãšãã«ããã·ã«40ã¢ã«ïŒ ãã¢ã¯ãªã«é žããã«50
ã¢ã«ïŒ ããã³ããã«ãããªãã³10ã¢ã«ïŒ ãããª
ãå ±éåäœã25ééïŒ ã®å²åã§å«æããé ¢é žãš
ãã«æº¶æ¶²ã調補ããããã®æº¶æ¶²ã«å ±éåäœïŒåº
圢åïŒ100éééšã«å¯ŸããŠãè¬ç©ãšããŠã€ã³ã
ã¡ã¿ã·ã³ïŒéééšãçµç®åžåä¿é²å€ãšããŠã©ãŠ
ãªã³é žãžãšã¿ããŒã«ã¢ããïŒéééšãæ·»å ã
ããããã«é ¢é žãšãã«ãå ããŠåºåœ¢åã15éé
ïŒ ãšããå¯éç³»æ¹ææ©å ã§å åã«æ¹æãããã
ããçé¢ãã·ãªã³ãŒã³åŠçãããããªãšãã¬ã³
ãã¬ãã¿ã¬ãŒãïŒPETïŒãã€ã«ã äžã«ä¹Ÿç¥åŸ
ã®åãã60ÎŒïœãšãªãããã«å¡åžãã70âã®ã®
ã¢ãªãŒãã³ã§20åé也ç¥ãããåŸãããç²çå€
局衚é¢ã«å¥é¢çŽãšããŠããªãšãã¬ã³ãã€ã«ã ã
ã©ãããŒãããããã®å¥é¢çŽã¯äœ¿çšæã«å¥é¢é€
å»ãããã (B) ç²çå€ã®æ§èœè©äŸ¡ è¬ç©ééæ§è©ŠéšïŒ(A)é ã§åŸããã貌ä»å€ã
çšããin vitroæ¡æ£ã»ã«ã«ããè¬å€ééæ§è©Š
éšãè¡ãªã€ãã24æéåŸã®è¬ç©ééçïŒïŒ ïŒ
ãè¡šïŒã«ç€ºããè©Šéšæ³ã¯æ¬¡ã®ãšããã§ããã in vitroæ¡æ£ã»ã«ã«ããè¬å€ééæ§è©Šéšæ³ïŒé
å£åŸã25cmã®ãã©ã³ã圢æ¡æ£ã»ã«ãæºåãããã
ã©ã³ã圢æ¡æ£ã»ã«ã®ã¬ã»ãã¿ãŒéšã«ã¯PH7.2ã«èª¿
æŽããççé£å¡©æ°Žãå ¥ãããã®å€å£ã«ã¯37âã®æž©
æ°Žã埪ç°ãããŠã¬ã»ãã¿ãŒéšã®æž©åºŠãäžå®ã«ä¿
ã€ãæ£åžžå®¶å ïŒéïŒã®è±æ¯åŠçããèè ¹éšã®è¡šç®
ïŒïŒcmÃïŒcmïŒã«(A)é ã§åŸããã貌ä»å€ã®è©Šéšç
ïŒçŽåŸ20mmã®åç¶ç©ïŒã貌ä»ãã該衚ç®ãã»ã«ã«
è£ çãããç®èãšã¬ã»ãã¿ãŒæ¶²é¢ãšã®éã«æ°æ³¡ã
å ¥ããªãããã«æ³šæããã¬ã»ãã¿ãŒæ¶²ãæºããã
24æéåŸã«ã¬ã»ãã¿ãŒæ¶²ããµã³ããªã³ã°ããéçž
ç³»ã«ã©ã ãçšããé«é液äœã¯ãããã°ã©ãã€ã«ã
ãè¬ç©æ¿åºŠã枬å®ããäžèšåŒããè¬å€ééçãç®
åºããã è¬å€ééçïŒïŒ ïŒ ïŒè¬å€æ¿åºŠÃã¬ã»ãã¿ãŒå®¹éïŒè©Šéšçã«å«æãããè¬
ç©éÃ100 è¬å€è¡äžæ¿åºŠïŒ(A)é ã§åŸããã貌ä»å€ãçš
ããin vivoè¡äžæ¿åºŠã®æž¬å®ã次ã®æ¹æ³ã§è¡
ãªã€ãããã®çµæã第ïŒå³ã«ç€ºãã in vivoè¡äžæ¿åºŠæž¬å®æ³ïŒ(A)é ã§åŸããã
貌ä»å€ãïŒcmÃ7.5cmã®å€§ããã«è£æããã
ããæ£åžžå®¶å ïŒéïŒã®è±æ¯ããèéšã®ç®èè¡š
é¢ã«è²Œä»ãããïŒæéåŸãïŒæéåŸãïŒæé
åŸãïŒæéåŸããã³24æéåŸã«å®¶å ã®è³ä»é
èããæ¡è¡ãè¡ãªãããã®è¡æž äžã®è¬å€æ¿åºŠ
ãéçžç³»ã«ã©ã ãçšããŠé«é液äœã¯ãããã°
ã©ãã€ãŒã§æž¬å®ããã 第ïŒå³ããæ¬å®æœäŸã§åŸããã貌ä»å€ãçš
ãããšè¬ç©ã®è¡äžèŸ²åºŠãé«ããè¬ç©ã®ç®èé
éæ§ã«åªããŠããããšãããããè¡äžæ¿åºŠæ²
ç·äžé¢ç©ïŒAUCïŒã¯14074±2778ã§ãããåŸ
è¿°ã®çµç®åžåä¿é²å€ãå ããŠããªãæ¯èŒäŸïŒ
ã®4992±434ã«æ¯ã¹ãŠçŽ2.8åã®é«ãå€ã瀺ã
ãã è¬ç©æŸåºæ§è©ŠéšïŒ(A)é ã§åŸããã貌ä»å€ã
çšããè¬ç©æŸåºæ§è©Šéšã次ã®æ¹æ³ã§è¡ãªã€
ãããã®çµæãè¡šïŒã§ç€ºãã è¬å€æŸåºæ§è©ŠéšïŒ(A)é ã§åŸããã貌ä»å€ã
çŽåŸ52mmã®å圢ã«è£æããŠè©ŠéšçãåŸããã
ã®è©Šéšçãæ枩氎槜å ã«37âã«ä¿ã€ãPH7.0
ã®10ïœïŒãªã³é žç·©è¡æ¶²250mlã«æµžæŒ¬ããŠæ¹æ
ããã10ååŸã20ååŸã40ååŸã60ååŸã
120ååŸããã³180ååŸã«ãªã³é žç·©è¡æ¶²ãå°é
ãã€æ¡åããéçžç³»ã«ã©ã ãçšããé«é液äœ
ã¯ãããã°ã©ãã€ãŒã«ãã溶åºè¬å€éã枬å®
ãããäžèšåŒããè¬ç©æº¶åºçãç®åºããã è¬å€æº¶åºçïŒïŒ ïŒ ïŒæº¶åºè¬å€éïŒè©Šéšçã«å«æãããè¬å€éÃ100 æ¯èŒäŸ ïŒ (A) 貌ä»å€ïŒããŒã補å€ïŒã®èª¿è£œïŒçµç®åžåä¿é²
å€ãšããŠãªã¬ã€ã³é žããªãªãã·ãšãã«ã¢ããã
çšããããšä»¥å€ã¯å®æœäŸïŒ(A)é ãšåæ§ã§ããã (B) ç²çå€ã®æ§èœè©äŸ¡ è¬å€ééæ§è©ŠéšïŒæ¬æ¯èŒäŸ(A)é ã§åŸããã貌
ä»å€ãçšããå®æœäŸïŒ(B)é ã«æºããŠè¡ãªã€
ãããã®çµæãè¡šïŒã«ç€ºãã æ¯èŒäŸ ïŒ (A) 貌ä»å€ïŒããŒã補å€ïŒã®èª¿è£œïŒçµç®åžåä¿é²
å€ãšããŠå°¿çŽ ãçšããããšä»¥å€ã¯å®æœäŸïŒ(A)é
ãšåæ§ã§ããã (B) ç²çå€ã®è£œé è©äŸ¡ è¬å€ééæ§è©ŠéšïŒæ¬æ¯èŒäŸ(A)é ã§åŸããã
貌ä»å€ãçšããå®æœäŸïŒ(B)é ã«æºããŠè¡ãª
ã€ãããã®çµæãè¡šïŒã«ç€ºãã è¬å€æŸåºæ§è©ŠéšïŒæ¬æ¯èŒäŸ(A)é ã§åŸããã
貌ä»å€ãçšããå®æœäŸïŒ(B)é ã«æºããŠè¡ãª
ã€ãããã®çµæãè¡šïŒã«ç€ºãã æ¯èŒäŸ ïŒ (A) 貌ä»å€ïŒããŒã補å€ïŒã®èª¿è£œïŒçµç®åžåä¿é²
å€ãšããŠã¢ãžãã³é žãžã€ãœãããã«ãçšããã
ãšä»¥å€ã¯å®æœäŸïŒ(A)é ãšåæ§ã§ããã (B) ç²çå€ã®æ§èœè©äŸ¡ è¬å€ééæ§è©ŠéšïŒæ¬æ¯èŒäŸ(A)é ã§åŸããã
貌ä»å€ãçšããå®æœäŸïŒ(B)é ã«æºããŠè¡ãª
ã€ãããã®çµæãè¡šïŒã«ç€ºãã è¬å€æŸåºæ§è©ŠéšïŒæ¬æ¯èŒäŸ(A)é ã§åŸããã
貌ä»å€ãçšããå®æœäŸïŒ(B)é ã«æºããŠè¡ãª
ã€ãããã®çµæãè¡šïŒã«ç€ºãã æ¯èŒäŸ ïŒ (A) 貌ä»å€ïŒããŒã補å€ïŒã®èª¿è£œïŒçµç®åžåä¿é²
å€ãšããŠãããã¬ã³ã°ãªã³ãŒã«ãçšããããšä»¥
å€ã¯å®æœäŸïŒ(A)é ãšåæ§ã§ããã (B) ç²çå€ã®æ§èœè©äŸ¡ è¬å€ééæ§è©ŠéšïŒæ¬æ¯èŒäŸ(A)é ã§åŸããã
貌ä»å€ãçšããå®æœäŸïŒ(B)é ã«æºããŠè¡ãª
ã€ãããã®çµæãè¡šïŒã«ç€ºãã è¬å€æŸåºæ§è©ŠéšïŒæ¬æ¯èŒäŸ(A)é ã§åŸããã
貌ä»å€ãçšããå®æœäŸïŒ(B)é ã«æºããŠè¡ãª
ã€ãããã®çµæãè¡šïŒã«ç€ºãã æ¯èŒäŸ ïŒ (A) 貌ä»å€ïŒããŒã補å€ïŒã®èª¿è£œïŒçµç®åžåä¿é²
å€ãå ããªãã€ãããšä»¥å€ã¯å®æœäŸïŒ(A)é ãšå
æ§ã§ããã (B) ç²çå€ã®æ§èœè©äŸ¡ è¬å€ééæ§è©ŠéšïŒæ¬æ¯èŒäŸ(A)é ã§åŸããã
貌ä»å€ãçšããå®æœäŸïŒ(B)é ã«æºããŠè¡ãª
ã€ãããã®çµæãè¡šïŒã«ç€ºãã è¬å€è¡äžæ¿åºŠïŒæ¬æ¯èŒäŸ(A)é ã§åŸããã貌
ä»å€ãçšããå®æœäŸïŒ(B)é ã«æºããŠè¡ãªã€
ãããã®çµæã第ïŒå³ã«ç€ºãã è¬å€æŸåºæ§è©ŠéšïŒæ¬æ¯èŒäŸ(A)é ã§åŸããã
貌ä»å€ãçšããå®æœäŸïŒ(B)é ã«æºããŠè¡ãª
ã€ãããã®çµæãè¡šïŒã«ç€ºãã
ãªã©ã®çµç®æäžåœ¢è£œå€ããã³ïŒãŸãã¯å£è å€ãç¹
çŒå€ã®ãªã©ã®çµç²èæäžåœ¢è£œå€ã«é¢ãããæ¬çºæ
ã¯ãç¹ã«ã該è¬ç©ã®åžåæ§ãé«ããçµç®ã»çµç²è
補å€ã«é¢ããã ïŒåŸæ¥ã®æè¡ïŒ å šèº«ãããã¯å±éšã§ã®è¬å¹ãåŸãããã«ãçµç®
æäžåœ¢è£œå€ããã³ïŒãŸãã¯çµç²èæäžåœ¢è£œå€ãçš
ããè¬ç©ïŒæŽç掻æ§ç©è³ªïŒãç®èãŸãã¯ç²èãä»
ããŠåžåãããããšãè¡ãããŠããããã®çµç®ã»
çµç²èæäžæ³ã¯ãåŸæ¥ã®çµå£æäžæ³ã«æ¯ã¹ãŠå©ç¹
ãå€ããäŸãã°ãè¬ç©ãçµå£æäžãããšãè žã§åž
åãããè¬ç©ã¯èèãžåŸªç°ããŠä»£è¬ãåããã
ãããã®è¬å¹ãçºæ®ããåã«ããªãã®éãå解ã
ããŠããŸããããã«å¯ŸããŠãçµç®ã»çµç²èæäžæ³
ã§ã¯ãåžåãããè¬ç©ã¯äœå ã®åå埪ç°æã«èè
ãééããªãããã®ãããèèã§ã®ä»£è¬ã«ããè¬
å¹ãå€§å¹ ã«æžãããšããããšããªããéã¹ããã€
ãç³»æççå€ãçµå£æäžãããšèè žé害ãçãã
ããããçµç®ã»çµç²èæäžã§ã¯ãã®ãããªèè žé
害ãçãã«ãããè¬ç©ã®åžåæ§ãã³ã³ãããŒã«ã
ãã°ãè¬ç©ãçæéã«å€§éã«åžåãããããã«èµ·
ããå¯äœçšã軜æžããããšãå¯èœãšãªããé·æé
ã«ãããäžå®ã®è¡äžæ¿åºŠãç¶æã§ããã°è¬ç©ãšæ
äžåæ°ãæžããããšãã§ããã ããããçµç®ã»çµç²è補å€ãçšããŠè¬ç©ãæäž
ããŠãã該è¬ç©ãç®èãç²èãééãã«ããçäœ
å©çšçïŒãã€ãªã¢ãã€ã©ããªãã€ïŒãäœããªãå Ž
åãå€ããç¹ã«ãç®èè¡šé¢ã«ã¯è§è³ªå±€ãååšãã
ãã®è§è³ªå±€ã¯äœå ãžç°ç©ãäŸµå ¥ããã®ãé²ãããª
ã¢ãŒæ©èœãæãããããè¬çå¹æãçºæ®ãããã«
å åãªéã®è¬ç©ãç®èãéããŠåžåãããªãå Žå
ãå€ãã è§è³ªå±€ã®ããªã€ãŒæ©èœã匱ããŠå åãªéã®è¬ç©
ãåžåãããã¹ãåžåä¿é²å€ãå«æããã補å€ã
補é ãããŠãããäŸãã°ãç¹éæ57â9714å·å ¬
å ±ãç¹å ¬æ58â43368å·å ¬å ±ãç¹éæ58â52216å·
å ¬å ±ãç¹éæ58â79918å·å ¬å ±ãç¹éæ60â13720
å·å ¬å ±ããã³ç¹éæ60â11431å·å ¬å ±ã«ã¯ãåžå
ä¿é²å€ãç²çå€å±€ã«å«æããã貌ä»å€ãªã©ãé瀺
ãããŠããã äžèšåžåä¿é²å€ã®ãã¡ãäŸãã°ããµãªãã«é žã
å°¿çŽ ããžã¡ãã«ã¹ã«ããã·ãã¯è§è³ªã溶解ããã
ãšãç¥ãããŠããããããããæ·»å ããŠãè¬ç©ã®
çµç®åžåæ§ã¯å¿ ãããè¯å¥œã§ã¯ãªãããããã¬ã³
ã°ãªã³ãŒã«ãã°ãªã»ãªã³ããããªãã³ã«ã«ãã³é ž
ãœãŒããªã©ã¯è§è³ªå±€ã«æ°Žåãä¿æããåŸãããè¬
ç©åžåä¿é²å¹æãã»ãšãã©èªããããªãããžã¡ã
ã«ã¹ã«ããã·ããªã©ã¯ãç®èãç²èãåºæ¿ããŠçŽ
æããã¶ããçãããããã¢ãžãã³é žãžã€ãœãã
ãã«ãªã©ã®ãžã«ã«ãã³é žãšã¹ãã«ãèèªé žãšã¹ã
ã«ãç²çå€å±€ã«å«æãããŠããŒã補å€ãšãããšã
ç²çå€ãšè¬ç©ãšã®çžæº¶æ§ãäœäžãããããè¬ç©ã
ç²çå€ããæåºãããããç²çæ§ãäœäžããããš
ããããããªã°ãªã³ãŒã«é žã«ã«ã·ãŠã ãªã©ã®ã€ãª
ãŠå«æååç©ã¯æªæ¯ã®åå ãšããªããäžèšååç©
ã®ä»ãããªã¹ãã³é žãšã¹ãã«ãã¢ãžãã³é žãšã¹ã
ã«ãã©ãŠãªã«ç¡«é žãšã¹ãã«ãããªãªã³ã·ãšãã¬ã³
ã¢ã«ãã«ãšãŒãã«ãªã©ãé瀺ãããŠãããããã
ãã®åžåä¿é²å€ãçšããŠãç®èãããã¯ç²èãé
ããŠã®è¬ç©ã®åžåéã¯å¿ ãããå åã§ãããšã¯ã
ããªãããã®ããã«ãè¬ç©ãå¹æçã«åžåããã
ãçµç®ã»çµç²è補å€ã¯ããŸã åŸãããªãã®ãçŸç¶
ã§ããã ïŒçºæã解決ããããšããåé¡ç¹ïŒ æ¬çºæã¯äžèšåŸæ¥ã®æ¬ ç¹ã解決ãããã®ã§ã
ãããã®ç®çãšãããšããã¯ãå«æããè¬ç©ãå¹
æçã«ç®èãç²èãéããŠåžåãããã補å€ãæ
äŸããããšã«ãããæ¬çºæã®ä»ã®ç®çã¯ãå«æã
ããè¬ç©ã®çµç®ã»çµç²èåžåæ§ãé«ãããã€ç®è
ãç²èã«å¯Ÿããåºæ¿æ§ããªãçäœã«å¯ŸããŠå®å šãª
åžåä¿é²å€ãå«æããçµç®ã»çµç²è補å€ãæäŸã
ãããšã«ãããæ¬çºæã®ããã«ä»ã®ç®çã¯ãåºå€
ã®æ§è³ªãå€åãããããšããªããããããè¬ç©ã
æåºããããšããªãããã€å«æãããè¬ç©ã®å€æ§
ãçããããšã®ãªãåžåä¿é²å€ãå«æããçµç®ã»
çµç²è補å€ãæäŸããããšã«ããã ïŒåé¡ç¹ã解決ããããã®ææ®µïŒ æ¬çºæã®çµç®ã»çµç²è補å€ã¯è¬ç©ããã³è©²è¬ç©
ã®åžåä¿é²å€ãå«æããçµç®ã»çµç²è補å€ã§ãã€
ãŠã該åžåä¿é²å€ãèèªé žãžã¢ã«ãããŒã«ã¢ãã
ã§ããã該èèªé žã®ççŽ æ°ãïŒã15ã§ããããã®
ããšã«ããäžèšç®çãéæãããã æ¬çºæã«çšããããåžåä¿é²å€ã¯ãäžèšåŒã§ç€º
ãããèèªé žãžã¢ã«ãããŒã«ã¢ããã§ããã ããã§R1ã¯ççŽ æ°ïŒã14ã®èèªæçåæ°ŽçŽ
åºïŒR2ã¯ççŽ æ°ïŒãïŒã®é£œåçåæ°ŽçŽ åºã§ããã äžèšååç©ã圢æãããèèªé žã¯ããã®ççŽ æ°
ãïŒã15ïŒçžåœããR1ã®ççŽ æ°ã¯ïŒã14ïŒã§ã
ãã奜ãŸããã¯10ã14ã§ãããççŽ æ°ãïŒã15ã®
ç¯å²ãå€ãããšè£œå€ã«å«æãããè¬ç©ã®åžåæ§ã
äœäžãããèèªé žãšããŠã¯ãã«ããªã«é žããã©ã«
ãŽã³é žãã«ããªã³é žãã©ãŠãªã³é žãããªã¹ãã³é ž
ãªã©ãæããããããããã¯ïŒçš®ä»¥äžæ··åããŠçš
ããããŠãããã ãããã®èèªé žã«ãžã¢ã«ãããŒã«ã¢ãã³HN
ïŒR2OHïŒ2ãçž®åããããšäžèšååç©ãåŸãããã
䜿çšããããžã¢ã«ãããŒã«ã¢ãã³ã®é£œåçåæ°ŽçŽ
åºR2ã¯ããã®ççŽ æ°ãïŒãïŒã§ãããççŽ æ°ã
ãã®ç¯å²å ã«ãããŠã¯ãççŽ æ°ã®å°ããã»ã©è¬ç©
ã®åžåæ§ã¯è¯å¥œã§ããããžã¢ã«ãããŒã«ã¢ãã³ãš
ããŠã¯ããžãšã¿ããŒã«ã¢ãã³ããžã€ãœãããããŒ
ã«ã¢ãã³ããžãã¿ããŒã«ã¢ãã³ããžãããµããŒã«
ã¢ãã³ãªã©ãããããã®ããã«ããŠåŸãããåžå
ä¿é²å€ã®ãã¡ã©ãŠãªã³é žãšãžãšã¿ããŒã«ã¢ãã³ã
çž®åããã©ãŠãªã³é žãžãšã¿ããŒã«ã¢ãããç¹ã«åª
ããå¹æã瀺ãã äžèšåžåä¿é²å€ã¯äžè¬ã«ã補å€äžã«0.01ã30é
éïŒ ã®å²åã§å«æãããããã®å²åã¯ãè»èå€ã
ã¯ãªãŒã 補å€ãåå€ãç¹çŒå€ãªã©ã§ã¯è£œå€å šäœã«
察ããå«æéã瀺ããäŸãã°ãããŒã補å€ããã
ãå€ãªã©ã®è²Œä»å€ã§ã¯ãè¬ç©å«æå±€ã«å¯Ÿããå«æ
éã瀺ããåŸè¿°ã®è¬ç©å«æéã«ã€ããŠãåæ§ã§ã
ããåžåä¿é²å€ã®éãéå°ãããšè¬ç©ã®åžåä¿é²
å¹æãåŸãããªããéå°ã§ãã€ãŠãè¬ç©ã®åžåæ§
ã¯ãã以äžåäžããªãã°ããããäŸãã°ããŒã補
å€ã§ã¯ç²çç©æ§ãäœäžããç²çå€ãšã®çžæº¶æ§ãæª
åããå Žåãããã 䜿çšãããè¬ç©ïŒçç掻æ§ç©è³ªïŒã¯çµç®ã»çµç²
èæäžã«ããçäœèãééããããã®ã§ããã°ã
ããç¹ã«éå®ãããªããäŸãã°ãéã¹ããã€ãç³»
æççå€ãã¹ããã€ãç³»æççå€ãè¡ç®¡æ¡åŒµå€ã
æäžæŽèå€ãæé«è¡å§å€ãæè «çå€ãå±æ麻é
å€ããã«ã¢ã³å€ãæãã¹ã¿ãã³å€ãæåè¡å€ãå©
å°¿å€ãå粟ç¥è¬ãç¡ç è¬ãæçç©è³ªãæããã
ãã éã¹ããã€ãç³»æççå€ãšããŠã¯ããµãªãã«
é žãã¢ã¹ããªã³ãã¢ã»ãã¢ããããšã³ããžã¯ãã
ãšããã¯ãããªãŠã ãã€ãããããšã³ãã¹ãªã³ã
ãã¯ãããããã»ã³ãã±ãããããšã³ããã«ããš
ãã é žãã€ããããã¯ãããšã³ãããšã³ãã¢ã«ã¯
ãããšããã¯ãããšãã«ãã¿ãŸã³ãã¡ããã é žã
ã€ã³ãã¡ã¿ã·ã³ããã³ãã¶ãã¯ããããã·ã«ã ã
ãã«ã«ãããããšã³ãªã©ãããã ã¹ããã€ãç³»æççå€ãšããŠã¯ããããã³ã«ã
ãŸã³ããã¬ãããŸãã³ããã«ãªã·ããã³ã¢ã»ãã
ãããã«ããã·ã³ã«ãããã¡ãã«ãã¬ãããŸã
ã³ãé ¢é žãããã³ã«ããŸã³ãããªã¢ã ã·ããã³ã¢
ã»ãããããããµã¡ã¿ãŸã³ãé ¢é žãã¿ã¡ãµãŸã³ã
åèé žãžãã«ã³ã«ããã³ãããããªã³é žã¯ããã¿
ãŸãŒã«ããã«ãªã·ããããªã©ãããã è¡ç®¡æ¡åŒµå€ãšããŠã¯ããžã«ãã¢ãŒã ããã©ãã
ã«ãåç¡é žãã³ã¿ãšãªã¹ãªãŒãã«ããžããªãã¢ãŒ
ã«ãç¡é žã€ãœãœã«ãããªã©ãããã æäžæŽèå€ãšããŠã¯ãããããããŒã«ããã³ã
ããŒã«ããããžã³ãã¢ãžããªã³ããã©ããªã³ãã¢
ã«ãã¬ãããŒã«ãªã©ããããæé«è¡å§å€ãšããŠ
ã¯ãã¯ãããžã³ãªã©ããããæè «çå€ãšããŠã¯ã
ïŒâãã«ãªããŠã©ã·ã«ãïŒâïŒïŒâããã©ããã
ããªã«ïŒâïŒâãã«ãªããŠã©ã·ã«ããã€ããã€ã·
ã³ïŒ£ãªã©ããããå±æ麻é å€ãšããŠã¯ããã³ãŸã«
ã€ã³ãããã«ã€ã³ããªãã«ã€ã³ãããã©ã«ã€ã³ãª
ã©ãããããã«ã¢ã³å€ãšããŠã¯ããšã¹ããã²ã³ã
ãšã¹ãã©ãžãªãŒã«ããã¹ãã¹ããã³ãããã²ã¹ã
ãã³ãªã©ã®ã¹ããã€ããã«ã¢ã³é¡ïŒã€ã³ã¹ãªã³ãª
ã©ã®ãããããã«ã¢ã³é¡ïŒããã¹ã¿ã°ã©ã³ãžã³ãª
ã©ããããæãã¹ã¿ãã³å€ãšããŠã¯ãã·ã¯ããã
ã¿ãžã³ãã€ããã¯ãã©ã€ãããžããšã³ããã©ã
ã³ãããšã³ãã³ã¶ãã³ãªã©ããããæåè¡è¬ãšã
ãŠã¯ãããªã³ãªã©ããå©å°¿å€ãšããŠã¯ãµã€ã¢ã¶ã€
ããªã©ããå粟ç¥å€ãšããŠã¯ã¹ã³ãã©ãã³ãã¯ã
ãã«ãããŒãŠãªã©ããããç¡ç è¬ãšããŠã¯ããšã
ãã«ãã¿ãŒã«ãã¢ã¢ãã«ãã¿ãŒã«ãªã©ãïŒæçç©
質ãšããŠã¯ããã©ãµã€ã¯ãªã³ãã¯ãã©ã ããšãã³
ãŒã«ãªã©ãããããããè¬ç©ã®é åéã¯ãè¬ç©ã®
çš®é¡ã補å€ã®äœ¿çšç®çãªã©ã«ããç°ãªãããé
åžžãè¬ç©ã¯è£œå€äžã«0.1ã30ééïŒ ã®å²åã§å«æ
ãããã ãããã®è¬ç©ãšäžèšåžåä¿é²å€ãšãå«æããæ¬
çºæã®çµç®ã»çµç²è補å€ã®ãã¡çµç®æäžå補å€ãš
ããŠã¯ãããŒã補å€ããããå€ããããå€ãè»è
å€ãã¯ãªãŒã 補å€ãªã©ããããçµç²èæäžå補å€
ãšããŠã¯ãåå€ãå£è å€ãç¹éŒ»å€ãç¹çŒå€ãªã©ã
ããã äžèšè£œå€ã®ãã¡ããŒã補å€ããããå€ã¯ãæ¯æ
äœã®çé¢ã«è¬ç©ãšåžåä¿é²å€ãšãå«æããç²çå€
å±€ã圢æãããŠãããããŒã補å€ããããå€ã®åº
å€ïŒç²çå€ïŒã¯è©²è£œå€ãåžžæž©ã§ç®èè¡šé¢ã«é·æé
åºå®ãããç²çåãããã°å åã§ãããç¹ã«éå®
ãããªããäŸãã°ã¢ã¯ãªã«ç³»ããŽã ç³»ãã·ãªã³ãŒ
ã³æš¹èç³»ãªã©ã®ç²çå€ãå©çšããåŸãéåžžãã¢ã¯
ãªã«ç³»ããã³ãŽã ç³»ã®ç²çå€ãçšããããã ã¢ã¯ãªã«ç³»ç²çå€ã§ã¯ããã®ç²çç©æ§ãªã©ã
ããç¹ã«ãççŽ æ°ïŒã18ã®èèªæã¢ã«ã³ãŒã«ãš
ïŒã¡ã¿ïŒã¢ã¯ãªã«é žãšããåŸãããïŒã¡ã¿ïŒã¢ã¯
ãªã«é žã¢ã«ãã«ãšã¹ãã«ã®ïŒå ±ïŒéåäœããã³ïŒ
ãŸãã¯äžèšïŒã¡ã¿ïŒã¢ã¯ãªã«é žã¢ã«ãã«ãšã¹ãã«
ãšãã®ä»ã®å®èœæ§ã¢ãããŒãšã®å ±éåäœã奜é©ã«
çšããããã äžèšïŒã¡ã¿ïŒã¢ã¯ãªã«é žãšã¹ãã«ãšããŠã¯ãã¢
ã¯ãªã«é žããã«ãã¢ã¯ãªã«é žã€ãœããã«ãã¢ã¯ãª
ã«é žããã·ã«ããã¢ã¯ãªã«é žãªã¯ãã«ãã¢ã¯ãªã«
é žïŒãšãã«ããã·ã«ãã¢ã¯ãªã«é žã€ãœãªã¯ãã«ã
ã¢ã¯ãªã«é žãã·ã«ãã¢ã¯ãªã«é žã€ãœãã·ã«ãã¢ã¯
ãªã«é žã©ãŠãªã«ãã¢ã¯ãªã«é žã¹ãã¢ãªã«ãã¡ã¿ã¯
ãªã«é žã¡ãã«ãã¡ã¿ã¯ãªã«é žãšãã«ãã¡ã¿ã¯ãªã«
é žããã«ãã¡ã¿ã¯ãªã«é žã€ãœããã«ãã¡ã¿ã¯ãªã«
é žïŒãšãã«ããã·ã«ãã¡ã¿ã¯ãªã«é žã€ãœãªã¯ã
ã«ãã¡ã¿ã¯ãªã«é žãã·ã«ãã¡ã¿ã¯ãªã«é žã€ãœãã·
ã«ãã¡ã¿ã¯ãªã«é žã©ãŠãªã«ãã¡ã¿ã¯ãªã«é žã¹ãã¢
ãªã«ãªã©ãããã äžèšå®èœæ§ã¢ãããŒã«ã¯ãæ°Žé žåºãæããã¢ã
ããŒãã«ã«ããã·ã«åºãæããã¢ãããŒãã¢ãã
åºãæããã¢ãããŒãã¢ããåºãæããã¢ãããŒ
ãªã©ãæãããããæ°Žé žåºãæããã¢ãããŒãšã
ãŠã¯ãïŒâããããã·ãšãã«ïŒã¡ã¿ïŒã¢ã¯ãªã¬ãŒ
ããããããã·ãããã«ïŒã¡ã¿ïŒã¢ã¯ãªã¬ãŒããª
ã©ã®ããããã·ã¢ã«ãã«ïŒã¡ã¿ïŒã¢ã¯ãªã¬ãŒãã
ãããã«ã«ããã·ã«åºãæããã¢ãããŒãšããŠ
ã¯ãã¢ã¯ãªã«é žãã¡ã¿ã¯ãªã«é žãªã©ã®Î±âβäžé£œ
åã«ã«ãã³é žïŒãã¬ã€ã³é žããã«ãªã©ã®ãã¬ã€ã³
é žã¢ãã¢ã«ãã«ãšã¹ãã«ïŒãã¬ã€ã³é žïŒããã«
é žïŒã¯ããã³é žãªã©ããããç¡æ°Žãã¬ã€ã³é žãã
ã¬ã€ã³é žãšåæ§ã®ïŒå ±ïŒéåæåãäžãããã¢ã
ãåºãæããã¢ãããŒãšããŠã¯ãã¢ã¯ãªã«ã¢ã
ãããžã¡ãã«ã¢ã¯ãªã«ã¢ããããžãšãã«ã¢ã¯ãªã«
ã¢ãããªã©ã®ã¢ã«ãã«ïŒã¡ã¿ïŒã¢ã¯ãªã«ã¢ããïŒ
ãããã·ã¡ãã«ã¢ã¯ãªã«ã¢ããããšããã·ã¡ãã«
ã¢ã¯ãªã«ã¢ãããªã©ã®ã¢ã«ãã«ãšãŒãã«ã¡ãããŒ
ã«ïŒã¡ã¿ïŒã¢ã¯ãªã«ã¢ãããªã©ããããã¢ããåº
ãæããã¢ãããŒãšããŠã¯ããžã¡ãã«ã¢ããã¢ã¯
ãªã¬ãŒããªã©ãããã äžèšä»¥å€ã®å ±éåæ§ã¢ãããŒãšããŠé ¢é žãã
ã«ãã¹ãã¬ã³ãαâã¡ãã«ã¹ãã¬ã³ãå¡©åãã
ã«ãã¢ã¯ãªãããªã«ããšãã¬ã³ããããã¬ã³ãã
ã¿ãžãšã³ãªã©ãæãããããããããå ±éåãã
ãŠããŠããããç²çå€äžïŒã¡ã¿ïŒã¢ã¯ãªã«é žã¢ã«
ãã«ãšã¹ãã«ãïŒå ±ïŒéåæåãšããŠ50ééïŒ ä»¥
äžå«æãããããšã奜ãŸããã ãŽã ç³»ç²çå€ãšããŠã¯ã倩ç¶ãŽã ãããªã€ãœã
ã¬ã³ãããªã€ãœããã¬ã³ãããªããã«ãšãŒãã«ã
ããªãŠã¬ã¿ã³ãããªãã¿ãžãšã³ãã¹ãã¬ã³âãã¿
ãžãšã³å ±éåäœãã¹ãã¬ã³âã€ãœãã¬ã³å ±éåäœ
ãªã©ãçšãããããã·ãªã³ãŒã³æš¹èç³»ç²çå€ãšã
ãŠã¯ãããªãªã«ã¬ãã·ãããµã³ãªã©ã®ã·ãªã³ãŒã³
ãŽã ãçšããããããããã®ã»ããããªé ¢é žãã
ã«ã倩ç¶ãã¯ã«ãªã©ãå©çšããããã äžèšç²çå€äžã«ã¯å¿ èŠã«å¿ããŠåçš®é åå€ãäŸ
ãã°ããžã³ç³»æš¹èãããªãã«ãã³æš¹èãã¯ããã³
âã€ã³ãã³æš¹èãç³æ²¹ç³»æš¹èããã«ãã³ããšããŒ
ã«æš¹èãªã©ã®ç²çæ§ä»äžå€ïŒæ¶²ç¶ããªããã³ãé±
æ²¹ã©ããªã³ã液ç¶ããªã€ãœãã¬ã³ã液ç¶ããªã¢ã¯
ãªã¬ãŒããªã©ã®å¯å¡å€ïŒå å¡«å€ïŒèåé²æ¢å€ïŒã
æ·»å ãããã ããŒã補å€ããããå€ãããã³åŸè¿°ã®ãããå€
ã®æ¯æäœãšããŠã¯ã貌ä»å€ã«éåžžå©çšãããæ¯æ
äœãçšããããããã®ãããªæ¯æäœã®çŽ æãšããŠ
ã¯ãé ¢é žã»ã«ããŒã¹ããšãã«ã»ã«ããŒã¹ãããªãš
ãã¬ã³ãã¬ãã¿ã¬ãŒããé ¢é žããã«âå¡©åããã«
å ±éåäœããã€ãã³ããšãã¬ã³âé ¢é žããã«å ±é
åäœãå¯å¡åããªå¡©åããã«ãããªãŠã¬ã¿ã³ãã
ãªãšãã¬ã³ãããªå¡©åãããªãã³ãã¢ã«ãããŠã
ãªã©ãããããããã¯ãäŸãã°ãåå±€ã®ã·ãŒã
ïŒãã€ã«ã ïŒãäºæ以äžã®ç©å±€ïŒã©ãããŒãïŒäœ
ãšããŠçšãããããã¢ã«ãããŠã 以å€ã®çŽ æã¯ç¹
åžãäžç¹åžãšããŠå©çšããŠãããã äžèšæ¯æäœè¡šé¢ã«è¬ç©ãšåžåä¿é²å€ãšãå«æã
ãè¬ç©å«æïŒç²çå€ïŒå±€ã圢æãããŠããŒã補å€
ããããå€ãåŸããããç²çå€å±€ã圢æããã«
ã¯ã溶å€å¡å·¥æ³ããããã¡ã«ãå¡å·¥æ³ãé»åç·ç¡¬
åãšãã«ãžãšã³å¡å·¥æ³ãªã©çš®ã ã®å¡å·¥æ³ãçšãã
ãããããªãã§ã溶å€å¡å·¥æ³ã奜é©ã«çšããã
ãã溶å€å¡å·¥æ³ã§ç²çå€å±€ã圢æããã«ã¯ãäŸã
ã°ãç²çå€ãé©åœãªæº¶åªã§çšéããããã«è¬ç©ã
åžåä¿é²å€ãããã«å¿ èŠã«å¿ããŠé åå€ãå ããŠ
åäžã«æ··åããåŸããã溶液ãæ¯æäœè¡šé¢ã«å¡
åžã»ä¹Ÿç¥ããã溶液ãçŽæ¥æ¯æäœè¡šé¢ã«å¡åžãã
ã«ã·ãªã³ãŒã³æš¹èãªã©ãã³ãŒãã€ã³ã°ããå¥é¢çŽ
äžã«å¡åžãã也ç¥åŸã«æ¯æäœã®å¯çãããŠãã
ãããã®ãããªå¥é¢çŽã¯ã䜿çšæãŸã§è²Œä»å€ã®ç²
çå€å±€è¡šé¢ãä¿è·ããããã«çšããããã溶å€å¡
å·¥æ³ä»¥å€ã®å¡å·¥æ³ã«ãããŠãç²çå€å±€åœ¢æåŸãç²
çå€å±€è¡šé¢ä¿è·ã®ããã«å¥é¢çŽãé ããããšãæš
奚ããããç²çå€å±€ã®åã¿ã䜿çšç®çã«ããç°ãª
ãããéåžžã30ã200ÎŒïœã§ããã80ÎŒïœãäžãŸã
ããšå¿ èŠéã®è¬ç©ãå«æããããšãã§ãããç²ç
æ§ãäžå åã§ããã200ÎŒïœãäžãŸãããšæ¯æäœ
ä»è¿ã®ç²çå€å±€ã«å«æãããè¬ç©ãå åã«æ¡æ£ã
ããè¬ç©æŸåºæ§ãäœäžããã ãããå€ãæ¯æäœã®çé¢ã«è¬ç©ãåžåä¿é²å€ã
å«æããè¬ç©å«æå±€ã圢æãããŠãããéåžžãã
ãŒã補å€ããããå€ã«æ¯ã¹ãŠç²çæ§ã«ä¹ãããã
çµåµèãªã©ã§ç®èè¡šé¢ãžåºå®ãããããããå€ã®
åºå€ã®äž»æåãšããŠã¯ãéåžžã氎溶æ§ã®ããªããŒ
ã䜿çšãããããã®ãããªããªããŒãšããŠã¯ãäŸ
ãã°ãã¢ã©ãã¢ã¬ã ããã©ã¬ã³ãã¬ã ãããŒã«ã¹
ãããŒã³ã¬ã ãã°ã¢ãŒã¬ã ããšã³ãŒã¬ã ãã«ã©ã€
ãŽã ãå¯å€©ããã³ãã³ãã«ã©ã²ãã³ãã¢ã«ã®ã³
é žãã¢ã«ã®ã³é žå¡©ïŒäŸãã°ã¢ã«ã®ã³é žãœãŒãïŒã
ã¢ã«ã®ã³é žãããã¬ã³ã°ãªã³ãŒã«ãããã¹ãã©
ã³ãããã¹ããªã³ãã¢ãããŒã¹ããŒã©ãã³ãã³ã©
ãŒã²ã³ããã«ã©ã³ããã¯ãã³ãã¢ãããã¯ãã³ã
ã¹ã¿ãŒããã¢ãããã¯ãã³ã»ãã°ãªã³ãŒã«é žãã
ãªãŠã ãããã³ãã¢ã«ããã³ãã«ãŒã€ã³ãããªã°
ã«ã¿ãã³é žãããªã¢ã¹ãã©ã®ã³é žãªã©ã®å€©ç¶ããª
ããŒïŒã¡ãã«ã»ã«ããŒã¹ããšãã«ã»ã«ããŒã¹ãã
ããã«ã»ã«ããŒã¹ããšãã«ã¡ãã«ã»ã«ããŒã¹ãã
ãããã·ã»ã«ããŒã¹ãããããã·ã¢ã«ãã«ã»ã«ã
ãŒã¹ãããããã·ãããã«ã¡ãã«ã»ã«ããŒã¹ãã
ãããã·ãããã«ã¹ã¿ãŒããã«ã«ããã·ã¡ãã«ã¹
ã¿ãŒããã¢ã«ã«ãªéå±ã«ã«ããã·ã¡ãã«ã»ã«ããŒ
ã¹ãã¢ã«ã«ãªéå±ã»ã«ããŒã¹ç¡«é žå¡©ãã»ã«ããŒã¹
ã¢ã»ããŒããã¿ã¬ãŒãããã³ãã³âã¢ã¯ãªã«é žã°
ã©ããéåäœãæ¶æ©ãŒã©ãã³ãç¡æ°Žãã¿ã«é žå€æ§
ãŒã©ãã³ãã³ãã¯é žå€æ§ãŒã©ãã³ãªã©ã®ååæã
ãªããŒïŒããªããã«ã¢ã«ã³ãŒã«ãããªããã«ãã
ãªãã³ãããªããã«ã¡ãã«ãšãŒãã«ãã¡ãã«ãã
ã«ãšã¹ãã«ãããªã¢ã¯ãªã«é žå¡©ïŒäŸãã°ããªã¢ã¯
ãªã«é žãœãŒãïŒãã«ã«ããã·ããã«ããªããŒãã
ãã«ãããªãã³âãªã¯ãªã«é žãšãã«å ±éåäœãã
ãã«ãããªãã³âã¹ãã¬ã³å ±éåäœãããã«ãã
ãªãã³âé ¢é žããã«å ±éåäœãããªããã«ã¢ã»ã
ãŒãâïŒã¡ã¿ïŒã¢ã¯ãªã«é žå ±éåäœãããªããã«
ã¢ã»ããŒãâã¯ããã³é žå ±éåäœãé ¢é žããã«â
ïŒã¡ã¿ïŒã¢ã¯ãªã«é žå ±éåäœãé ¢é žããã«âã¯ã
ãã³é žå ±éåäœãããªããã«ã¹ã«ãã³é žãããªã€
ã¿ã³ã³é žãããªããããã·ãšãã«ã¢ã¯ãªã¬ãŒãã
ããªã¢ã¯ãªã«ã¢ãããã¹ãã¬ã³âãã¬ã€é žç¡æ°Žç©
å ±éåäœããšãã¬ã³âãã¬ã€ã³é žç¡æ°Žç©å ±éå
äœãã¢ã¯ãªã«ã¢ããâã¢ã¯ãªã«é žå ±éåäœãªã©ã®
åæããªããŒãããã äžèšæ°Žæº¶æ§ããªããŒãæ°Žãè¬ç©ããã³åžåä¿é²
å€ãåäžã«æ··åãã氎溶æ§ããªããŒåã³æ°Žãããª
ãå«æ°Žåºå€ã«è¬ç©åã³åžåä¿é²å€ãå«æãããè¬
ç©å«æå±€ãåèšæ¯æäœè¡šé¢ã«åœ¢æããŠææã®ãã
ãå€ãåŸãããã åãäžèšæ°Žæº¶æ§ããªããŒä»¥å€ã®åèšã¢ã¯ãªã«ç³»
ããªããŒããŽã ç³»ããªããŒãã·ãªã³ã³ç³»ããªããŒ
çã®é氎溶æ§ããªããŒã«æ°Žãå«æãããŠå«æ°Žåºå€
ãæ§æããããã«è¬ç©åã³åžåä¿é²å€åã³å¿ èŠã«
å¿ã氎溶æ§ããªããŒãå ããŠè¬ç©å«æå±€ãšãªããŠ
ãããå€ãåŸãããšãå¯èœã§ããã å«æ°Žåºå€ã«å«æãããæ°Žã®éã¯åºå€ãè¬ç©ãã
ã³åžåä¿é²å€ãå«ã補å€ã®ïŒã90ééïŒ ãã奜ãŸ
ããã¯ïŒã90ééïŒ ã§ããããã®ããã«æ°Žãå«æ
ãããããšã«ãããå«æ°Žåºå€ãæ§æãããããã
ã¯åŸè¿°ããè»èå€ãã¯ãªãŒã 補å€ã®å Žåãåæ§ã§
ãããæ°Žãäžèšç¯å²ã§å«æããããšè¬ç©ã®åžåä¿
é²å€ã®å¹æãå€§å¹ ã«å¢åŒ·ããããæ°Žã®éãéå°ã§
ãããšè¬ç©ã®åžåä¿é²å€ãããŸã倧ãããªããã
ã€è£œå€ãç®èè¡šé¢ãžå¯çãããšãã«æ°Žåã®èžçºã«
ããå·æå¹æãåŸãããªããæ°Žã®éãéå°ã§ãã
ãšæµåæ§ã倧ãããªãã補å€ã®åœ¢ç¶ãä¿ã€ã®ãé£
ãããªãã äžèšè¬ç©å«æå±€ã«ã¯ããã«ãå€äŸ¡ã¢ã«ã³ãŒã«
ïŒäŸãã°ãã°ãªã»ãªã³ããããã¬ã³ã°ãªã³ãŒã«ïŒ
ãªã©ã®ä¿æ¹¿å€ïŒã«ãªãªã³ããã³ããã€ããäºé
è¯ãäºé žåãã¿ã³ãªã©ã®ç¡æ©å å¡«å€ïŒç²åºŠèª¿æŽ
å€ïŒæ¶æ©å€ïŒèåé²æ¢å€ïŒãªã©ãå«æããããŠã
ããã è»èå€ãã¯ãªãŒã 補å€ã®åºå€ã®äž»æåã«ã¯ãã
ããŠãæ²¹èãã©ããªã³ãçœè²ã¯ã»ãªã³ããã©ãã€
ã³ããã©ã¹ãããŒã¹ããŒã¬ã³50WïŒåååïŒãé«çŽ
èèªé žãé«çŽã¢ã«ã³ãŒã«ãä¹³åå€ããã¯ããŽãŒ
ã«ãã«ã«ããã·ããã«ããªããŒãªã©ãããããã
ãååç©ã«è¬ç©ãšåžåä¿é²å€ãšãæ··åãããŠè»è
å€ãã¯ãªãŒã 補å€ãåŸããããæ··åæã«ã¯ãå¿ èŠ
ã«å¿ããŠã¯ãã¿ããã³ãæµåãã©ãã€ã³ãããªã¹
ãã³é žã€ãœãããã«ãã»ãã·ã³é žãžãšãã«ãªã©ã®
è溶æ§æº¶è§£å€ïŒç²Ÿè£œæ°ŽïŒãšã¿ããŒã«ãå€äŸ¡ã¢ã«ã³
ãŒã«ïŒäŸãã°ã°ãªã»ãªã³ïŒãªã©ã®æ°Žæº¶æ§æº¶è§£å€ïŒ
PH調æŽå€ïŒãªã©ãæ·»å ãããã å£è å€ãç¹éŒ»å€ãç¹çŒå€ãè»èç¶ãã¯ãªãŒã ç¶
ã§ããå Žåã«ã¯ãäžèšè»èå€ãã¯ãªãŒã 補å€ã®åº
å€ãçšããããè»èå€ãã¯ãªãŒã å€ãšåæ§ã®æ¹æ³
ã§èª¿æŽãããã溶液ïŒæžæ¿æ¶²ïŒããŒãªãŒç¶ã§ãã
å Žåã«ã¯ãäŸãã°ããšã¿ããŒã«ã粟補氎ãã°ãªã³
ãŒã«é¡ã«è¬ç©ãåžåä¿é²å€ã溶解ãããã¯æžæ¿ã
ããŠææã®è£œå€ãåŸãããããã©ã¬ã³ããã¢ã©ã
ã¢ãŽã ãã¢ã«ã®ã³é žãããªãŠã ããŒã©ãã³ãã¡ã¿
ã«ã»ã«ããŒã¹ãã«ã«ããã·ã¡ãã«ã»ã«ããŒã¹
ïŒCMCïŒãªã©ã®æ°Žæº¶æ§ããªããŒãšæ°Žãšã®æ··å液ã«
è¬ç©ãåžåä¿é²å€ã溶解ãããã¯åæ£ãããå Žå
ããããå£è å€ã®ãã¡å£å€çšè²Œä»å€ãšããŠã¯ãã
ãŒã補å€ããããå€ããããå€ãšåã圢æ ã®è²Œä»
å€ãçšããããšãã§ãããäŸãã°ãåºå€ã«è¬ç©ãš
åžåä¿é²å€ãšãå ããŠè¬ç©å«æãã€ã«ã ã調補
ãããã®è¡šé¢ã«è¬ç©ãéããã®ãé²ãããã«éæ°Ž
溶æ§ãã€ã«ã ãç©å±€ããç©å±€äœãå©çšããããã åå€ã®åºå€ãšããŠã¯ã«ã«ãªèãããŒã æ²¹ãã€ã·
æ²¹ãåç»ã³ã³ãããæ²¹ãªã©ã®æ²¹èïŒã¯ã»ãªã³ãªã©
ã䜿çšããããäžèšåºå€ã«è¬ç©ãšåžåä¿é²å€ãšã
åäžã«æ··åããåå€æååšãçšããŠææã®åå€ã
調補ãããã ïŒäœçšïŒ æ¬çºæã®çµç®ã»çµç²è補å€ãç®èãããã¯ç²è
è¡šé¢ã«å¯çããããšå«æãããè¬ç©ã容æã«ç®è
ãããã¯ç²èãéããŠåžåãããããã®è©³çŽ°ãªæ©
æ§ã¯äžæã§ããããåžåä¿é²å€ãç®èãããã¯ç²
èã«äœ¿çšãããã®èçœè³ªãå€æ§ãããå«æ°Žçãäž
æãããŠè»åããããããšèããããããã®ã
ããéåžžãè¬ç©ãééãã«ããç®èè¡šé¢ã®è§è³ªå±€
ãè»åããŠå«æãããè¬ç©ã容æã«ç®èãéããŠ
åžåããããšèããããã å¿ èŠãªè¬ç©ãåŸãã®ã«å åãªéã®è¬ç©ã容æã«
åžåããããããåŸæ¥ã®ããã«å€§éã®è¬ç©ã補å€
äžã«å«æãããå¿ èŠããªããã€ãŸããè¬ç©ã®ãã€
ãªã¢ãã€ã©ããªãã€ãé«ãããã®ãããªçµç®ã»çµ
ç²èåžåä¿é²å¹æã¯åŸæ¥ã®åžåä¿é²å€ãçšãããš
ããããã¯ããã«é«ããããã«ãæ¬çºæã«çšãã
åžåä¿é²å€ã¯ç®èãç²èã«å¯Ÿããåºæ¿æ§ããªãå®
å šæ§ãé«ããå«æãããè¬ç©ãå€æ§ãããããšã
ãªããåºå€ãšã®çžæº¶æ§ã«ãåªãããè¬ç©ãšåºå€ãš
ã®çžæº¶æ§ã«å€åãäžããªãããã調補åŸã®è£œå€ã
ãè¬ç©ãæåºããããšããªããããŒã補å€ããã
ãå€ãšãããšãã«ã¯ãåžåä¿é²å€èªäœãç²çå€ã®
ç²çæ©èœãäœäžããããªã©ç²çå€ã®ç©æ§ã«æªåœ±é¿
ããããŒãããšããªãã ïŒå®æœäŸïŒ 以äžã«æ¬çºæãå®æœäŸã«ã€ããŠèª¬æããã å®æœäŸ ïŒ (A) 貌ä»å€ïŒããŒã補å€ïŒã®èª¿è£œïŒã¢ã¯ãªã«é žïŒ
ãšãã«ããã·ã«40ã¢ã«ïŒ ãã¢ã¯ãªã«é žããã«50
ã¢ã«ïŒ ããã³ããã«ãããªãã³10ã¢ã«ïŒ ãããª
ãå ±éåäœã25ééïŒ ã®å²åã§å«æããé ¢é žãš
ãã«æº¶æ¶²ã調補ããããã®æº¶æ¶²ã«å ±éåäœïŒåº
圢åïŒ100éééšã«å¯ŸããŠãè¬ç©ãšããŠã€ã³ã
ã¡ã¿ã·ã³ïŒéééšãçµç®åžåä¿é²å€ãšããŠã©ãŠ
ãªã³é žãžãšã¿ããŒã«ã¢ããïŒéééšãæ·»å ã
ããããã«é ¢é žãšãã«ãå ããŠåºåœ¢åã15éé
ïŒ ãšããå¯éç³»æ¹ææ©å ã§å åã«æ¹æãããã
ããçé¢ãã·ãªã³ãŒã³åŠçãããããªãšãã¬ã³
ãã¬ãã¿ã¬ãŒãïŒPETïŒãã€ã«ã äžã«ä¹Ÿç¥åŸ
ã®åãã60ÎŒïœãšãªãããã«å¡åžãã70âã®ã®
ã¢ãªãŒãã³ã§20åé也ç¥ãããåŸãããç²çå€
局衚é¢ã«å¥é¢çŽãšããŠããªãšãã¬ã³ãã€ã«ã ã
ã©ãããŒãããããã®å¥é¢çŽã¯äœ¿çšæã«å¥é¢é€
å»ãããã (B) ç²çå€ã®æ§èœè©äŸ¡ è¬ç©ééæ§è©ŠéšïŒ(A)é ã§åŸããã貌ä»å€ã
çšããin vitroæ¡æ£ã»ã«ã«ããè¬å€ééæ§è©Š
éšãè¡ãªã€ãã24æéåŸã®è¬ç©ééçïŒïŒ ïŒ
ãè¡šïŒã«ç€ºããè©Šéšæ³ã¯æ¬¡ã®ãšããã§ããã in vitroæ¡æ£ã»ã«ã«ããè¬å€ééæ§è©Šéšæ³ïŒé
å£åŸã25cmã®ãã©ã³ã圢æ¡æ£ã»ã«ãæºåãããã
ã©ã³ã圢æ¡æ£ã»ã«ã®ã¬ã»ãã¿ãŒéšã«ã¯PH7.2ã«èª¿
æŽããççé£å¡©æ°Žãå ¥ãããã®å€å£ã«ã¯37âã®æž©
æ°Žã埪ç°ãããŠã¬ã»ãã¿ãŒéšã®æž©åºŠãäžå®ã«ä¿
ã€ãæ£åžžå®¶å ïŒéïŒã®è±æ¯åŠçããèè ¹éšã®è¡šç®
ïŒïŒcmÃïŒcmïŒã«(A)é ã§åŸããã貌ä»å€ã®è©Šéšç
ïŒçŽåŸ20mmã®åç¶ç©ïŒã貌ä»ãã該衚ç®ãã»ã«ã«
è£ çãããç®èãšã¬ã»ãã¿ãŒæ¶²é¢ãšã®éã«æ°æ³¡ã
å ¥ããªãããã«æ³šæããã¬ã»ãã¿ãŒæ¶²ãæºããã
24æéåŸã«ã¬ã»ãã¿ãŒæ¶²ããµã³ããªã³ã°ããéçž
ç³»ã«ã©ã ãçšããé«é液äœã¯ãããã°ã©ãã€ã«ã
ãè¬ç©æ¿åºŠã枬å®ããäžèšåŒããè¬å€ééçãç®
åºããã è¬å€ééçïŒïŒ ïŒ ïŒè¬å€æ¿åºŠÃã¬ã»ãã¿ãŒå®¹éïŒè©Šéšçã«å«æãããè¬
ç©éÃ100 è¬å€è¡äžæ¿åºŠïŒ(A)é ã§åŸããã貌ä»å€ãçš
ããin vivoè¡äžæ¿åºŠã®æž¬å®ã次ã®æ¹æ³ã§è¡
ãªã€ãããã®çµæã第ïŒå³ã«ç€ºãã in vivoè¡äžæ¿åºŠæž¬å®æ³ïŒ(A)é ã§åŸããã
貌ä»å€ãïŒcmÃ7.5cmã®å€§ããã«è£æããã
ããæ£åžžå®¶å ïŒéïŒã®è±æ¯ããèéšã®ç®èè¡š
é¢ã«è²Œä»ãããïŒæéåŸãïŒæéåŸãïŒæé
åŸãïŒæéåŸããã³24æéåŸã«å®¶å ã®è³ä»é
èããæ¡è¡ãè¡ãªãããã®è¡æž äžã®è¬å€æ¿åºŠ
ãéçžç³»ã«ã©ã ãçšããŠé«é液äœã¯ãããã°
ã©ãã€ãŒã§æž¬å®ããã 第ïŒå³ããæ¬å®æœäŸã§åŸããã貌ä»å€ãçš
ãããšè¬ç©ã®è¡äžèŸ²åºŠãé«ããè¬ç©ã®ç®èé
éæ§ã«åªããŠããããšãããããè¡äžæ¿åºŠæ²
ç·äžé¢ç©ïŒAUCïŒã¯14074±2778ã§ãããåŸ
è¿°ã®çµç®åžåä¿é²å€ãå ããŠããªãæ¯èŒäŸïŒ
ã®4992±434ã«æ¯ã¹ãŠçŽ2.8åã®é«ãå€ã瀺ã
ãã è¬ç©æŸåºæ§è©ŠéšïŒ(A)é ã§åŸããã貌ä»å€ã
çšããè¬ç©æŸåºæ§è©Šéšã次ã®æ¹æ³ã§è¡ãªã€
ãããã®çµæãè¡šïŒã§ç€ºãã è¬å€æŸåºæ§è©ŠéšïŒ(A)é ã§åŸããã貌ä»å€ã
çŽåŸ52mmã®å圢ã«è£æããŠè©ŠéšçãåŸããã
ã®è©Šéšçãæ枩氎槜å ã«37âã«ä¿ã€ãPH7.0
ã®10ïœïŒãªã³é žç·©è¡æ¶²250mlã«æµžæŒ¬ããŠæ¹æ
ããã10ååŸã20ååŸã40ååŸã60ååŸã
120ååŸããã³180ååŸã«ãªã³é žç·©è¡æ¶²ãå°é
ãã€æ¡åããéçžç³»ã«ã©ã ãçšããé«é液äœ
ã¯ãããã°ã©ãã€ãŒã«ãã溶åºè¬å€éã枬å®
ãããäžèšåŒããè¬ç©æº¶åºçãç®åºããã è¬å€æº¶åºçïŒïŒ ïŒ ïŒæº¶åºè¬å€éïŒè©Šéšçã«å«æãããè¬å€éÃ100 æ¯èŒäŸ ïŒ (A) 貌ä»å€ïŒããŒã補å€ïŒã®èª¿è£œïŒçµç®åžåä¿é²
å€ãšããŠãªã¬ã€ã³é žããªãªãã·ãšãã«ã¢ããã
çšããããšä»¥å€ã¯å®æœäŸïŒ(A)é ãšåæ§ã§ããã (B) ç²çå€ã®æ§èœè©äŸ¡ è¬å€ééæ§è©ŠéšïŒæ¬æ¯èŒäŸ(A)é ã§åŸããã貌
ä»å€ãçšããå®æœäŸïŒ(B)é ã«æºããŠè¡ãªã€
ãããã®çµæãè¡šïŒã«ç€ºãã æ¯èŒäŸ ïŒ (A) 貌ä»å€ïŒããŒã補å€ïŒã®èª¿è£œïŒçµç®åžåä¿é²
å€ãšããŠå°¿çŽ ãçšããããšä»¥å€ã¯å®æœäŸïŒ(A)é
ãšåæ§ã§ããã (B) ç²çå€ã®è£œé è©äŸ¡ è¬å€ééæ§è©ŠéšïŒæ¬æ¯èŒäŸ(A)é ã§åŸããã
貌ä»å€ãçšããå®æœäŸïŒ(B)é ã«æºããŠè¡ãª
ã€ãããã®çµæãè¡šïŒã«ç€ºãã è¬å€æŸåºæ§è©ŠéšïŒæ¬æ¯èŒäŸ(A)é ã§åŸããã
貌ä»å€ãçšããå®æœäŸïŒ(B)é ã«æºããŠè¡ãª
ã€ãããã®çµæãè¡šïŒã«ç€ºãã æ¯èŒäŸ ïŒ (A) 貌ä»å€ïŒããŒã補å€ïŒã®èª¿è£œïŒçµç®åžåä¿é²
å€ãšããŠã¢ãžãã³é žãžã€ãœãããã«ãçšããã
ãšä»¥å€ã¯å®æœäŸïŒ(A)é ãšåæ§ã§ããã (B) ç²çå€ã®æ§èœè©äŸ¡ è¬å€ééæ§è©ŠéšïŒæ¬æ¯èŒäŸ(A)é ã§åŸããã
貌ä»å€ãçšããå®æœäŸïŒ(B)é ã«æºããŠè¡ãª
ã€ãããã®çµæãè¡šïŒã«ç€ºãã è¬å€æŸåºæ§è©ŠéšïŒæ¬æ¯èŒäŸ(A)é ã§åŸããã
貌ä»å€ãçšããå®æœäŸïŒ(B)é ã«æºããŠè¡ãª
ã€ãããã®çµæãè¡šïŒã«ç€ºãã æ¯èŒäŸ ïŒ (A) 貌ä»å€ïŒããŒã補å€ïŒã®èª¿è£œïŒçµç®åžåä¿é²
å€ãšããŠãããã¬ã³ã°ãªã³ãŒã«ãçšããããšä»¥
å€ã¯å®æœäŸïŒ(A)é ãšåæ§ã§ããã (B) ç²çå€ã®æ§èœè©äŸ¡ è¬å€ééæ§è©ŠéšïŒæ¬æ¯èŒäŸ(A)é ã§åŸããã
貌ä»å€ãçšããå®æœäŸïŒ(B)é ã«æºããŠè¡ãª
ã€ãããã®çµæãè¡šïŒã«ç€ºãã è¬å€æŸåºæ§è©ŠéšïŒæ¬æ¯èŒäŸ(A)é ã§åŸããã
貌ä»å€ãçšããå®æœäŸïŒ(B)é ã«æºããŠè¡ãª
ã€ãããã®çµæãè¡šïŒã«ç€ºãã æ¯èŒäŸ ïŒ (A) 貌ä»å€ïŒããŒã補å€ïŒã®èª¿è£œïŒçµç®åžåä¿é²
å€ãå ããªãã€ãããšä»¥å€ã¯å®æœäŸïŒ(A)é ãšå
æ§ã§ããã (B) ç²çå€ã®æ§èœè©äŸ¡ è¬å€ééæ§è©ŠéšïŒæ¬æ¯èŒäŸ(A)é ã§åŸããã
貌ä»å€ãçšããå®æœäŸïŒ(B)é ã«æºããŠè¡ãª
ã€ãããã®çµæãè¡šïŒã«ç€ºãã è¬å€è¡äžæ¿åºŠïŒæ¬æ¯èŒäŸ(A)é ã§åŸããã貌
ä»å€ãçšããå®æœäŸïŒ(B)é ã«æºããŠè¡ãªã€
ãããã®çµæã第ïŒå³ã«ç€ºãã è¬å€æŸåºæ§è©ŠéšïŒæ¬æ¯èŒäŸ(A)é ã§åŸããã
貌ä»å€ãçšããå®æœäŸïŒ(B)é ã«æºããŠè¡ãª
ã€ãããã®çµæãè¡šïŒã«ç€ºãã
ãè¡šã
ãè¡šã
è¡šïŒããå®æœäŸïŒã®è²Œä»å€ã¯ãçµç®åžåä¿é²å€
ãå«æããªãæ¯èŒäŸïŒã®è²Œä»å€ã«æ¯ã¹ãŠçŽ11åã®
åžåééçã瀺ãããšãããããåŸæ¥ã®çµç®åžå
ä¿é²å€ãå«æãã貌ä»å€ïŒæ¯èŒäŸïŒãïŒïŒãšæ¯èŒ
ããŠãçŽïŒå以äžãšãã極ããŠé«ãè¬å€ééçã
瀺ããã©ãŠãªã³é žãžãšã¿ããŒã«ã¢ãããåªããçµ
ç®åžåä¿é²å€ã§ããããšãæããã§ããã
ãå«æããªãæ¯èŒäŸïŒã®è²Œä»å€ã«æ¯ã¹ãŠçŽ11åã®
åžåééçã瀺ãããšãããããåŸæ¥ã®çµç®åžå
ä¿é²å€ãå«æãã貌ä»å€ïŒæ¯èŒäŸïŒãïŒïŒãšæ¯èŒ
ããŠãçŽïŒå以äžãšãã極ããŠé«ãè¬å€ééçã
瀺ããã©ãŠãªã³é žãžãšã¿ããŒã«ã¢ãããåªããçµ
ç®åžåä¿é²å€ã§ããããšãæããã§ããã
ãè¡šã
è¡šïŒããå®æœäŸïŒã®è²Œä»å€ã¯çµç®åžåä¿é²å€ã
å«æããªãæ¯èŒäŸïŒã®è²Œä»å€ãšã»ãŒåæ§ã®è¬å€æŸ
åºæ§ã瀺ãããšãããããããã¯ãçµç®åžåä¿é²
å€ãæ·»å ããŠãè¬ç©ãšç²çå€ãšã®çžæº¶æ§ãã»ãšã
ã©å€åããªããããšèããããã å®æœäŸ ïŒ (A) å£è ç²èçšè²Œä»å€ã®èª¿è£œïŒããªé ¢é žããã«40
éééšãå«æããé ¢é žã¡ãã«æº¶æ¶²ãšããããã·
ãããã«ã»ã«ããŒã¹20éééšãå«æããã¡ã¿ã
ãŒã«æº¶æ¶²ãšãæ··åããããã«ãããªã³13éééš
ããã³ã©ãŠãªã³é žãžãšã¿ããŒã«ã¢ããïŒåžåä¿
é²å€ïŒïŒéééšãå ããŠããŸã«ããŒã§åäžã«æ··
åããããããæµå»¶ä¹Ÿç¥ããŠåã0.35mmã®ãã€
ã«ã ãåŸãããã®ãã€ã«ã ã«åã0.1mmã®ããª
é ¢é žããã«è£œãã€ã«ã ãç©å±€ããŠå¯çãããã
ãã®ç©å±€äœã1.5cm2ã«æã¡æããŠå£è ç²èçšè²Œ
ä»å€ãåŸãã (B) å£è ç²èçšè²Œä»å€ã®æ§èœè©äŸ¡ïŒ(A)é ã§åŸãã
ã貌ä»å€ïŒãããªã³ 1050Uå«æïŒãããŒã°ã«
ç¬å£è å ã«è²Œä»ãã貌ä»0.5æéåŸãïŒæéåŸã
ïŒæéåŸããã³ïŒæéåŸã«åè¢éèããæ¡è¡ã
ãã¹ãããŒã ããããªã³ãããããçšããŠè¡äž
ãããªã³æ¿åºŠã枬å®ããããã®çµæãè¡šïŒã«ç€º
ãã æ¯èŒäŸ ïŒ (A) å£è ç²èçšè²Œä»å€ã®èª¿æŽïŒåžåä¿é²å€ãå ã
ãªãã€ãããšä»¥å€ã¯å®æœäŸïŒ(A)é ãšåæ§ã§ã
ãã (B) å£è ç²èçšè²Œä»å€ã®æ§èœè©äŸ¡ïŒæ¬æ¯èŒäŸ(A)é
ã§åŸããã貌ä»å€ãçšããŠå®æœäŸïŒ(B)é ãšåæ§
ã«è¡ã€ãããã®çµæãè¡šïŒã«ç€ºãã
å«æããªãæ¯èŒäŸïŒã®è²Œä»å€ãšã»ãŒåæ§ã®è¬å€æŸ
åºæ§ã瀺ãããšãããããããã¯ãçµç®åžåä¿é²
å€ãæ·»å ããŠãè¬ç©ãšç²çå€ãšã®çžæº¶æ§ãã»ãšã
ã©å€åããªããããšèããããã å®æœäŸ ïŒ (A) å£è ç²èçšè²Œä»å€ã®èª¿è£œïŒããªé ¢é žããã«40
éééšãå«æããé ¢é žã¡ãã«æº¶æ¶²ãšããããã·
ãããã«ã»ã«ããŒã¹20éééšãå«æããã¡ã¿ã
ãŒã«æº¶æ¶²ãšãæ··åããããã«ãããªã³13éééš
ããã³ã©ãŠãªã³é žãžãšã¿ããŒã«ã¢ããïŒåžåä¿
é²å€ïŒïŒéééšãå ããŠããŸã«ããŒã§åäžã«æ··
åããããããæµå»¶ä¹Ÿç¥ããŠåã0.35mmã®ãã€
ã«ã ãåŸãããã®ãã€ã«ã ã«åã0.1mmã®ããª
é ¢é žããã«è£œãã€ã«ã ãç©å±€ããŠå¯çãããã
ãã®ç©å±€äœã1.5cm2ã«æã¡æããŠå£è ç²èçšè²Œ
ä»å€ãåŸãã (B) å£è ç²èçšè²Œä»å€ã®æ§èœè©äŸ¡ïŒ(A)é ã§åŸãã
ã貌ä»å€ïŒãããªã³ 1050Uå«æïŒãããŒã°ã«
ç¬å£è å ã«è²Œä»ãã貌ä»0.5æéåŸãïŒæéåŸã
ïŒæéåŸããã³ïŒæéåŸã«åè¢éèããæ¡è¡ã
ãã¹ãããŒã ããããªã³ãããããçšããŠè¡äž
ãããªã³æ¿åºŠã枬å®ããããã®çµæãè¡šïŒã«ç€º
ãã æ¯èŒäŸ ïŒ (A) å£è ç²èçšè²Œä»å€ã®èª¿æŽïŒåžåä¿é²å€ãå ã
ãªãã€ãããšä»¥å€ã¯å®æœäŸïŒ(A)é ãšåæ§ã§ã
ãã (B) å£è ç²èçšè²Œä»å€ã®æ§èœè©äŸ¡ïŒæ¬æ¯èŒäŸ(A)é
ã§åŸããã貌ä»å€ãçšããŠå®æœäŸïŒ(B)é ãšåæ§
ã«è¡ã€ãããã®çµæãè¡šïŒã«ç€ºãã
ãè¡šã
è¡šïŒããèèªé
žãžã¢ã«ãããŒã«ã¢ãããåžåä¿
é²å€ãšããæ¬çºæã®è£œå€ïŒå£è ç²èçšè²Œä»å€ïŒ
ã¯ãåžåä¿é²å€ç¡æ·»å 補å€ã«æ¯ã¹ãŠç²èãä»ããŠ
ã®è¬ç©åžåæ§ã«åªããŠããããšããããã å®æœäŸ ïŒ (A) åå€ã®èª¿è£œïŒãžã¯ãããšãã¯ãããªãŠã 5.0
éééšãã©ãŠãªã³é žãžãšã¿ããŒã«ã¢ããïŒåžå
ä¿é²å€ïŒïŒéééšãã«ã«ãªè93éééšãåäžã«
æ··åããåçç¶ã«æ圢ããŠ0.25ïœã®åå€ãåŸ
ãã (B) åå€ã®æ§èœè©äŸ¡ïŒæ¬å®æœäŸ(A)é ã§åŸãããå
å€ã家å ã®èéã«æäžãããæäž10ååŸã20å
åŸã40ååŸã60ååŸããã³120ååŸã«å®¶å è³ä»
éèããæ¡è¡ãè¡ã€ãããã®è¡æ¶²ããè¡æŒ¿ã
åŸããã³ãŒã³ã§æœåºåŸãæœåºç©ãECDã¬ã¹ã¯
ãããã°ã©ãã€ãŒã«ãããŠè¡æŒ¿äžã®è¬ç©ïŒãžã¯
ãããšãã¯ãããªãŠã ïŒã®å®éãè¡ã€ãããã®
çµæãè¡šïŒã«ç€ºãã æ¯èŒäŸ ïŒ (A) åå€ã®èª¿è£œïŒåžåä¿é²å€ãå ããªãã€ãããš
以å€ã¯å®æœäŸïŒ(A)ãšåæ§ã§ããã (B) åå€ã®æ§èœè©äŸ¡ïŒæ¬æ¯èŒäŸ(A)é ã§åŸãããå
å€ãçšããå®æœäŸïŒ(B)é ãšåæ§ã«è¡ã€ãããã®
çµæãè¡šïŒã«ç€ºãã
é²å€ãšããæ¬çºæã®è£œå€ïŒå£è ç²èçšè²Œä»å€ïŒ
ã¯ãåžåä¿é²å€ç¡æ·»å 補å€ã«æ¯ã¹ãŠç²èãä»ããŠ
ã®è¬ç©åžåæ§ã«åªããŠããããšããããã å®æœäŸ ïŒ (A) åå€ã®èª¿è£œïŒãžã¯ãããšãã¯ãããªãŠã 5.0
éééšãã©ãŠãªã³é žãžãšã¿ããŒã«ã¢ããïŒåžå
ä¿é²å€ïŒïŒéééšãã«ã«ãªè93éééšãåäžã«
æ··åããåçç¶ã«æ圢ããŠ0.25ïœã®åå€ãåŸ
ãã (B) åå€ã®æ§èœè©äŸ¡ïŒæ¬å®æœäŸ(A)é ã§åŸãããå
å€ã家å ã®èéã«æäžãããæäž10ååŸã20å
åŸã40ååŸã60ååŸããã³120ååŸã«å®¶å è³ä»
éèããæ¡è¡ãè¡ã€ãããã®è¡æ¶²ããè¡æŒ¿ã
åŸããã³ãŒã³ã§æœåºåŸãæœåºç©ãECDã¬ã¹ã¯
ãããã°ã©ãã€ãŒã«ãããŠè¡æŒ¿äžã®è¬ç©ïŒãžã¯
ãããšãã¯ãããªãŠã ïŒã®å®éãè¡ã€ãããã®
çµæãè¡šïŒã«ç€ºãã æ¯èŒäŸ ïŒ (A) åå€ã®èª¿è£œïŒåžåä¿é²å€ãå ããªãã€ãããš
以å€ã¯å®æœäŸïŒ(A)ãšåæ§ã§ããã (B) åå€ã®æ§èœè©äŸ¡ïŒæ¬æ¯èŒäŸ(A)é ã§åŸãããå
å€ãçšããå®æœäŸïŒ(B)é ãšåæ§ã«è¡ã€ãããã®
çµæãè¡šïŒã«ç€ºãã
ãè¡šã
è¡šïŒããèèªé
žãžã¢ã«ãããŒã«ã¢ãããåžåä¿
é²å€ãšããæ¬çºæã®è£œå€ïŒåå€ïŒã¯ãåžåä¿é²å€
ç¡æ·»å 補å€ã«æ¯ã¹ãŠç²èãä»ããŠã®è¬ç©åžåæ§ã«
åªããŠããããšããããã å®æœäŸ ïŒãïŒãïŒ (A) 貌ä»å€ïŒããŒã補å€ïŒã®èª¿è£œïŒã¢ã¯ãªã«é žïŒ
ãšãã«ããã·ã«40ã¢ã«ïŒ ãã¢ã¯ãªã«é žããã«50
ã¢ã«ïŒ ããã³ããã«ãããªãã³10ã¢ã«ïŒ ãããª
ãå ±éåäœãïŒééïŒ ã®å²åã§å«æããé ¢é žãš
ãã«æº¶æ¶²ã調補ããããã®æº¶æ¶²ã«å ±éåäœïŒåº
圢åïŒ100éééšã«å¯ŸããŠãè¬ç©ãšããŠã€ã³ã
ã¡ã¿ã·ã³ïŒéééšãçµç®åžåä¿é²å€ãšããŠã«ã
ãªã«é žãžãšã¿ããŒã«ã¢ãããŸãã¯ã«ããªã³é žãž
ãšã¿ããŒã«ã¢ãããŸãã¯ããªã¹ãã³é žãžãšã¿ã
ãŒã«ã¢ããã®ããããïŒéééšãæ·»å ãããã
ãã«é ¢é žãšãã«ãå ããŠåºåœ¢åã15ééïŒ ãš
ããå¯éç³»æ¹ææ©å ã§å åã«æ¹æãããããã
çé¢ãã·ãªã³ãŒã³åŠçãããããªãšãã¬ã³ãã¬
ãã¿ã¬ãŒãïŒPETïŒãã€ã«ã äžã«ä¹Ÿç¥åŸã®å
ãã60ÎŒïœãšãªãããã«å¡åžãã70âã®ã®ã¢ãª
ãŒãã³ã§20åé也ç¥ãããåŸãããç²çå€å±€è¡š
é¢ã«å¥é¢çŽãšããŠããªãšãã¬ã³ãã€ã«ã ãã©ã
ããŒãããäžçš®é¡ã®è²Œä»å€ãåŸãããã®å¥é¢çŽ
ã¯äœ¿çšæã«å¥é¢é€å»ãããã (B) 貌ä»å€ã®æ§èœè©äŸ¡ïŒ(A)é ã§åŸããã貌ä»å€ã
çšããin vitroæ¡æ£ã»ã«ã«ããè¬ç©ééæ§è©Šéš
ãè¡ãªã€ãã24æéåŸã®è¬ç©ééçïŒïŒ ïŒãè¡š
ïŒã«ç€ºããè©Šéšæ³ã¯å®æœäŸïŒ(B)é ã®è¬å€éé
æ§è©Šéšãšåãã§ããã æ¯èŒäŸ ïŒ (A) 貌ä»å€ïŒããŒã補å€ïŒã®èª¿è£œïŒåžåä¿é²å€ã
å ããªãã€ãããšä»¥å€ã¯å®æœäŸïŒãïŒãïŒ(A)é
ãšåæ§ã§ããã (B) 貌ä»å€ã®æ§èœè©äŸ¡ïŒæ¬æ¯èŒäŸ(A)é ã§åŸããã
貌ä»å€ãçšããå®æœäŸïŒãïŒãïŒ(B)é ãšåæ§ã«
è¡ã€ãããã®çµæãè¡šïŒã«ç€ºãã
é²å€ãšããæ¬çºæã®è£œå€ïŒåå€ïŒã¯ãåžåä¿é²å€
ç¡æ·»å 補å€ã«æ¯ã¹ãŠç²èãä»ããŠã®è¬ç©åžåæ§ã«
åªããŠããããšããããã å®æœäŸ ïŒãïŒãïŒ (A) 貌ä»å€ïŒããŒã補å€ïŒã®èª¿è£œïŒã¢ã¯ãªã«é žïŒ
ãšãã«ããã·ã«40ã¢ã«ïŒ ãã¢ã¯ãªã«é žããã«50
ã¢ã«ïŒ ããã³ããã«ãããªãã³10ã¢ã«ïŒ ãããª
ãå ±éåäœãïŒééïŒ ã®å²åã§å«æããé ¢é žãš
ãã«æº¶æ¶²ã調補ããããã®æº¶æ¶²ã«å ±éåäœïŒåº
圢åïŒ100éééšã«å¯ŸããŠãè¬ç©ãšããŠã€ã³ã
ã¡ã¿ã·ã³ïŒéééšãçµç®åžåä¿é²å€ãšããŠã«ã
ãªã«é žãžãšã¿ããŒã«ã¢ãããŸãã¯ã«ããªã³é žãž
ãšã¿ããŒã«ã¢ãããŸãã¯ããªã¹ãã³é žãžãšã¿ã
ãŒã«ã¢ããã®ããããïŒéééšãæ·»å ãããã
ãã«é ¢é žãšãã«ãå ããŠåºåœ¢åã15ééïŒ ãš
ããå¯éç³»æ¹ææ©å ã§å åã«æ¹æãããããã
çé¢ãã·ãªã³ãŒã³åŠçãããããªãšãã¬ã³ãã¬
ãã¿ã¬ãŒãïŒPETïŒãã€ã«ã äžã«ä¹Ÿç¥åŸã®å
ãã60ÎŒïœãšãªãããã«å¡åžãã70âã®ã®ã¢ãª
ãŒãã³ã§20åé也ç¥ãããåŸãããç²çå€å±€è¡š
é¢ã«å¥é¢çŽãšããŠããªãšãã¬ã³ãã€ã«ã ãã©ã
ããŒãããäžçš®é¡ã®è²Œä»å€ãåŸãããã®å¥é¢çŽ
ã¯äœ¿çšæã«å¥é¢é€å»ãããã (B) 貌ä»å€ã®æ§èœè©äŸ¡ïŒ(A)é ã§åŸããã貌ä»å€ã
çšããin vitroæ¡æ£ã»ã«ã«ããè¬ç©ééæ§è©Šéš
ãè¡ãªã€ãã24æéåŸã®è¬ç©ééçïŒïŒ ïŒãè¡š
ïŒã«ç€ºããè©Šéšæ³ã¯å®æœäŸïŒ(B)é ã®è¬å€éé
æ§è©Šéšãšåãã§ããã æ¯èŒäŸ ïŒ (A) 貌ä»å€ïŒããŒã補å€ïŒã®èª¿è£œïŒåžåä¿é²å€ã
å ããªãã€ãããšä»¥å€ã¯å®æœäŸïŒãïŒãïŒ(A)é
ãšåæ§ã§ããã (B) 貌ä»å€ã®æ§èœè©äŸ¡ïŒæ¬æ¯èŒäŸ(A)é ã§åŸããã
貌ä»å€ãçšããå®æœäŸïŒãïŒãïŒ(B)é ãšåæ§ã«
è¡ã€ãããã®çµæãè¡šïŒã«ç€ºãã
ãè¡šã
ãè¡šã
è¡šïŒããå®æœäŸïŒãïŒãïŒã®è²Œä»å€ã¯ãåžåä¿
é²å€ãå«æããªãæ¯èŒäŸïŒã®è²Œä»å€ã«æ¯ã¹ãŠçŽ15
ãïŒåã®è¬ç©ééçã瀺ãããšããããããã®ã
ãšãããã«ããªã«é žãžãšã¿ããŒã«ã¢ãã³ãã«ããª
ã³é žãžãšã¿ããŒã«ã¢ãã³ããã³ããªã¹ãã³é žãžãš
ã¿ããŒã«ã¢ãã³ããããããåªããåžåä¿é²å€ã§
ããããšãæããã§ããã å®æœäŸ ïŒ (A) 貌ä»å€ïŒãããå€ïŒã®èª¿è£œïŒãŒã©ãã³ïŒéé
éšãããªã¢ã¯ãªã«é žïŒéééšãã«ã«ããã·ã¡ã
ã«ã»ã«ããŒã¹ïŒéééšãããªããã«ãããªãã³
ïŒéééšãã«ãªãªã³ïŒéééšãæ°Žé žåã¢ã«ãã
ãŠã 0.5éééšãã°ãªã»ãªã³10éééšãã€ã³ã
ã¡ã¿ã·ã³ïŒè¬ç©ïŒïŒéééšãã©ãŠãã€ã«ãžãšã¿
ããŒã«ã¢ããïŒåžåä¿é²å€ïŒ2.5éééšããã³
粟補氎65éééšãåäžã«æ··åããŠããŒã¹ãç¶ã®
ãããçšèäœãåŸãããããäžç¹åžäžã«0.5mm
ã®åã¿ã«å¡åžããããªãšãã¬ã³ãã€ã«ã ã®ããš
ã€ã·ã³ã°ãæœããã (B) 貌ä»å€ã®æ§èœè©äŸ¡ïŒæ¬å®æœäŸ(A)é ã§åŸããã
貌ä»å€ãçšããin vitroæ¡æ£ã»ã«ã«ããè¬ç©é
éæ§è©Šéšãè¡ã€ãã24æéåŸã®è¬ç©ééç
ïŒïŒ ïŒãè¡šïŒã«ç€ºããè©Šéšæ³ã¯å®æœäŸïŒ(B)é
ãšåæ§ã§ããã æ¯èŒäŸ ïŒ (A) 貌ä»å€ïŒãããå€ïŒã®èª¿è£œïŒåžåä¿é²å€ãšã
ãŠããªãœã«ããŒã80ã0.5éééšçšããããšä»¥
å€ã¯å®æœäŸïŒ(A)é ãšåæ§ã§ããã (B) 貌ä»å€ã®æ§èœè©äŸ¡ïŒæ¬æ¯èŒäŸ(A)é ã§åŸããã
貌ä»å€ãçšããŠå®æœäŸïŒ(B)é ãšåæ§ã«è¡ã€ãã
ãã®çµæãè¡šïŒã«ç€ºãã å®æœäŸ ïŒ (A) 貌ä»å€ïŒãããå€ïŒã®èª¿è£œïŒè¬ç©ãšããŠã±ã
ããããšã³3.0éééšããããŠåžåä¿é²å€ãšã
ãŠã«ããªã³é žãžãšã¿ããŒã«ã¢ãã3.0éééšã
çšããããšä»¥å€ã¯å®æœäŸïŒ(A)é ãšåæ§ã§ããã (B) 貌ä»å€ã®æ§èœè©äŸ¡ïŒæ¬å®æœäŸ(A)é ã§åŸããã
貌ä»å€ãçšããŠå®æœäŸïŒ(B)é ãšåæ§ã«è¡ã€ãã
ãã®çµæãè¡šïŒã«ç€ºãã æ¯èŒäŸ 10 (A) 貌ä»å€ïŒãããå€ïŒã®èª¿è£œïŒåžåä¿é²å€ãšã
ãŠããªãœããŒã80ã0.5éééšçšããããšä»¥å€
ã¯å®æœäŸïŒ(A)é ãšåæ§ã§ããã (B) 貌ä»å€ã®æ§èœè©äŸ¡ïŒæ¬æ¯èŒäŸ(A)é ã§åŸããã
貌ä»å€ãçšããŠå®æœäŸïŒ(B)é ãšåæ§ã«è¡ã€ãã
ãã®çµæãè¡šïŒã«ç€ºãã
é²å€ãå«æããªãæ¯èŒäŸïŒã®è²Œä»å€ã«æ¯ã¹ãŠçŽ15
ãïŒåã®è¬ç©ééçã瀺ãããšããããããã®ã
ãšãããã«ããªã«é žãžãšã¿ããŒã«ã¢ãã³ãã«ããª
ã³é žãžãšã¿ããŒã«ã¢ãã³ããã³ããªã¹ãã³é žãžãš
ã¿ããŒã«ã¢ãã³ããããããåªããåžåä¿é²å€ã§
ããããšãæããã§ããã å®æœäŸ ïŒ (A) 貌ä»å€ïŒãããå€ïŒã®èª¿è£œïŒãŒã©ãã³ïŒéé
éšãããªã¢ã¯ãªã«é žïŒéééšãã«ã«ããã·ã¡ã
ã«ã»ã«ããŒã¹ïŒéééšãããªããã«ãããªãã³
ïŒéééšãã«ãªãªã³ïŒéééšãæ°Žé žåã¢ã«ãã
ãŠã 0.5éééšãã°ãªã»ãªã³10éééšãã€ã³ã
ã¡ã¿ã·ã³ïŒè¬ç©ïŒïŒéééšãã©ãŠãã€ã«ãžãšã¿
ããŒã«ã¢ããïŒåžåä¿é²å€ïŒ2.5éééšããã³
粟補氎65éééšãåäžã«æ··åããŠããŒã¹ãç¶ã®
ãããçšèäœãåŸãããããäžç¹åžäžã«0.5mm
ã®åã¿ã«å¡åžããããªãšãã¬ã³ãã€ã«ã ã®ããš
ã€ã·ã³ã°ãæœããã (B) 貌ä»å€ã®æ§èœè©äŸ¡ïŒæ¬å®æœäŸ(A)é ã§åŸããã
貌ä»å€ãçšããin vitroæ¡æ£ã»ã«ã«ããè¬ç©é
éæ§è©Šéšãè¡ã€ãã24æéåŸã®è¬ç©ééç
ïŒïŒ ïŒãè¡šïŒã«ç€ºããè©Šéšæ³ã¯å®æœäŸïŒ(B)é
ãšåæ§ã§ããã æ¯èŒäŸ ïŒ (A) 貌ä»å€ïŒãããå€ïŒã®èª¿è£œïŒåžåä¿é²å€ãšã
ãŠããªãœã«ããŒã80ã0.5éééšçšããããšä»¥
å€ã¯å®æœäŸïŒ(A)é ãšåæ§ã§ããã (B) 貌ä»å€ã®æ§èœè©äŸ¡ïŒæ¬æ¯èŒäŸ(A)é ã§åŸããã
貌ä»å€ãçšããŠå®æœäŸïŒ(B)é ãšåæ§ã«è¡ã€ãã
ãã®çµæãè¡šïŒã«ç€ºãã å®æœäŸ ïŒ (A) 貌ä»å€ïŒãããå€ïŒã®èª¿è£œïŒè¬ç©ãšããŠã±ã
ããããšã³3.0éééšããããŠåžåä¿é²å€ãšã
ãŠã«ããªã³é žãžãšã¿ããŒã«ã¢ãã3.0éééšã
çšããããšä»¥å€ã¯å®æœäŸïŒ(A)é ãšåæ§ã§ããã (B) 貌ä»å€ã®æ§èœè©äŸ¡ïŒæ¬å®æœäŸ(A)é ã§åŸããã
貌ä»å€ãçšããŠå®æœäŸïŒ(B)é ãšåæ§ã«è¡ã€ãã
ãã®çµæãè¡šïŒã«ç€ºãã æ¯èŒäŸ 10 (A) 貌ä»å€ïŒãããå€ïŒã®èª¿è£œïŒåžåä¿é²å€ãšã
ãŠããªãœããŒã80ã0.5éééšçšããããšä»¥å€
ã¯å®æœäŸïŒ(A)é ãšåæ§ã§ããã (B) 貌ä»å€ã®æ§èœè©äŸ¡ïŒæ¬æ¯èŒäŸ(A)é ã§åŸããã
貌ä»å€ãçšããŠå®æœäŸïŒ(B)é ãšåæ§ã«è¡ã€ãã
ãã®çµæãè¡šïŒã«ç€ºãã
ãè¡šã
è¡šïŒããèèªé
žãžã¢ã«ãããŒã«ã¢ãããåžåä¿
é²å€ãšããæ¬çºæã®è£œå€ïŒãããå€ïŒã¯ãåŸæ¥ã®
åžåä¿é²å€ãçšãã補å€ã«æ¯ã¹ãŠç®èãä»ããŠã®
è¬ç©ééæ§ã«åªããŠããããšããããã å®æœäŸ ïŒ (A) ã²ã«è»èã®èª¿è£œïŒãããªã³ïŒè¬ç©ïŒïŒéé
éšããã¯ããŽãŒã«400 10éééšãã«ã«ããã·ã
ãã«ããªããŒ1.5éééšããšã¿ããŒã«10éééšã
粟補氎71.5éééšããã³ã©ãŠãã€ã«ãžãšã¿ããŒ
ã«ã¢ããïŒåžåä¿é²å€ïŒïŒéééšãåäžã«æ··å
ããŠã²ã«è»èãåŸãã (B) ã²ã«è»èã®æ§èœè©äŸ¡ïŒæ¬å®æœäŸ(A)é ã§åŸãã
ãã²ã«è»è100mgïŒãããªã³ 770Uå«æïŒã家
å ã®è³ä»å åŽã«çŽïŒcm2ãšãªãããã«å¡åžããã
å¡åžéšäœååŸã®èŸºçžéèïŒïŒã±æïŒã«ã«ããŠãŒ
ã¬ãæ¿å ¥ããç匵液ãçŽ1.5mlïŒåã®å²åã§é
æµãããããã®éæµæ¶²äžã®ãããªã³ãããã¹ã
ããŒã ããããªã³ããããïŒç¬¬ïŒååŠè¬å瀟
補ïŒãçšããŠ405nïœã®åžå 床ã枬å®ããããš
ã«ããå®éããããããªã³ã®æž¬å®ã¯ã²ã«è»èå¡
åž0.5æéåŸãïŒæéåŸãïŒæéåŸããã³ïŒæ
éåŸã«è¡ã€ãããã®çµæãè¡šïŒã«ç€ºãã æ¯èŒäŸ 11 (A) ã²ã«è»èã®èª¿è£œïŒåžåä¿é²å€ãå ããªãã€ã
ããšä»¥å€ã¯å®æœäŸïŒ(A)é ãšåæ§ã§ããã (B) ã²ã«è»èã®æ§èœè©äŸ¡ïŒæ¬æ¯èŒäŸ(A)é ã§åŸãã
ãã²ã«è»èãçšããå®æœäŸïŒ(B)é ãšåæ§ã«è¡ã€
ãããã®çµæãè¡šïŒã«ç€ºãã
é²å€ãšããæ¬çºæã®è£œå€ïŒãããå€ïŒã¯ãåŸæ¥ã®
åžåä¿é²å€ãçšãã補å€ã«æ¯ã¹ãŠç®èãä»ããŠã®
è¬ç©ééæ§ã«åªããŠããããšããããã å®æœäŸ ïŒ (A) ã²ã«è»èã®èª¿è£œïŒãããªã³ïŒè¬ç©ïŒïŒéé
éšããã¯ããŽãŒã«400 10éééšãã«ã«ããã·ã
ãã«ããªããŒ1.5éééšããšã¿ããŒã«10éééšã
粟補氎71.5éééšããã³ã©ãŠãã€ã«ãžãšã¿ããŒ
ã«ã¢ããïŒåžåä¿é²å€ïŒïŒéééšãåäžã«æ··å
ããŠã²ã«è»èãåŸãã (B) ã²ã«è»èã®æ§èœè©äŸ¡ïŒæ¬å®æœäŸ(A)é ã§åŸãã
ãã²ã«è»è100mgïŒãããªã³ 770Uå«æïŒã家
å ã®è³ä»å åŽã«çŽïŒcm2ãšãªãããã«å¡åžããã
å¡åžéšäœååŸã®èŸºçžéèïŒïŒã±æïŒã«ã«ããŠãŒ
ã¬ãæ¿å ¥ããç匵液ãçŽ1.5mlïŒåã®å²åã§é
æµãããããã®éæµæ¶²äžã®ãããªã³ãããã¹ã
ããŒã ããããªã³ããããïŒç¬¬ïŒååŠè¬å瀟
補ïŒãçšããŠ405nïœã®åžå 床ã枬å®ããããš
ã«ããå®éããããããªã³ã®æž¬å®ã¯ã²ã«è»èå¡
åž0.5æéåŸãïŒæéåŸãïŒæéåŸããã³ïŒæ
éåŸã«è¡ã€ãããã®çµæãè¡šïŒã«ç€ºãã æ¯èŒäŸ 11 (A) ã²ã«è»èã®èª¿è£œïŒåžåä¿é²å€ãå ããªãã€ã
ããšä»¥å€ã¯å®æœäŸïŒ(A)é ãšåæ§ã§ããã (B) ã²ã«è»èã®æ§èœè©äŸ¡ïŒæ¬æ¯èŒäŸ(A)é ã§åŸãã
ãã²ã«è»èãçšããå®æœäŸïŒ(B)é ãšåæ§ã«è¡ã€
ãããã®çµæãè¡šïŒã«ç€ºãã
ãè¡šã
è¡šïŒããèèªé
žãžã¢ã«ãããŒã«ã¢ãããåžåä¿
é²å€ãšããæ¬çºæã®è£œå€ïŒã²ã«è»èïŒã¯ãåžåä¿
é²å€ç¡æ·»å å€ã«æ¯ã¹ãŠç®èãä»ããŠã®è¬ç©åžåæ§
ã«åªããŠããããšããããã å®æœäŸ 10 (A) ã²ã«è»èã®èª¿è£œïŒé ¢é žãããã³ã«ããŸã³ïŒé
ééšããã¯ããŽãŒã«400 10éééšãã«ã«ããã·
ããã«ããªããŒ1.5éééšããšã¿ããŒã«10éé
éšã粟補氎74éééšããã³ã«ããã³é žãžãã¿ã
ãŒã«ã¢ããïŒåžåä¿é²å€ïŒ2.5éééšãåäžã«
æ··åããŠã²ã«è»èãåŸãã (B) ã²ã«è»èã®æ§èœè©äŸ¡ïŒæ¬å®æœäŸ(A)é ã§åŸãã
ãã²ã«è»è100mgãçšãããããæ£åžžå®¶å ïŒéïŒ
ã®è±æ¯åŠçããèè ¹éšã®è¡šç®ã«å¡åžããå®æœäŸ
ïŒ(B)é ã«æºããŠin vitroæ¡æ£ã»ã«ã«ããè¬ç©
ééæ§è©Šéšãè¡ã€ãã24æéåŸã®è¬ç©ééç
ïŒïŒ ïŒãè¡šïŒã«ç€ºãã æ¯èŒäŸ 12 (A) åžåä¿é²å€ãå ããªãã€ãããšä»¥å€ã¯å®æœäŸ
10(A)é ãšåæ§ã§ããã (B) å®æœäŸ10(B)é ãšåæ§ã«è¡ã€ãããã®çµæã¯è¡š
ïŒã®éãã§ãã€ãã
é²å€ãšããæ¬çºæã®è£œå€ïŒã²ã«è»èïŒã¯ãåžåä¿
é²å€ç¡æ·»å å€ã«æ¯ã¹ãŠç®èãä»ããŠã®è¬ç©åžåæ§
ã«åªããŠããããšããããã å®æœäŸ 10 (A) ã²ã«è»èã®èª¿è£œïŒé ¢é žãããã³ã«ããŸã³ïŒé
ééšããã¯ããŽãŒã«400 10éééšãã«ã«ããã·
ããã«ããªããŒ1.5éééšããšã¿ããŒã«10éé
éšã粟補氎74éééšããã³ã«ããã³é žãžãã¿ã
ãŒã«ã¢ããïŒåžåä¿é²å€ïŒ2.5éééšãåäžã«
æ··åããŠã²ã«è»èãåŸãã (B) ã²ã«è»èã®æ§èœè©äŸ¡ïŒæ¬å®æœäŸ(A)é ã§åŸãã
ãã²ã«è»è100mgãçšãããããæ£åžžå®¶å ïŒéïŒ
ã®è±æ¯åŠçããèè ¹éšã®è¡šç®ã«å¡åžããå®æœäŸ
ïŒ(B)é ã«æºããŠin vitroæ¡æ£ã»ã«ã«ããè¬ç©
ééæ§è©Šéšãè¡ã€ãã24æéåŸã®è¬ç©ééç
ïŒïŒ ïŒãè¡šïŒã«ç€ºãã æ¯èŒäŸ 12 (A) åžåä¿é²å€ãå ããªãã€ãããšä»¥å€ã¯å®æœäŸ
10(A)é ãšåæ§ã§ããã (B) å®æœäŸ10(B)é ãšåæ§ã«è¡ã€ãããã®çµæã¯è¡š
ïŒã®éãã§ãã€ãã
ãè¡šã
å®æœäŸ 11
(A) 貌ä»å€ïŒããŒãå€ïŒã®èª¿è£œïŒå€©ç¶ãŽã 45éé
éšåã³ãã«ãã³æš¹è45éééšã®æ··åç©ã®10éé
ïŒ ã·ã¯ããããµã³æº¶æ¶²100éééšã«å¯Ÿãã€ãœãœ
ã«ãããžãã€ãã¬ãŒãïŒISDNïŒã®30ééïŒ å¡©
åã¡ãã¬ã³æº¶æ¶²3.704éééšãæ·»å ãããã«ã©
ãŠãªã³é žãžãããããŒã«ã¢ããïŒåžåä¿é²å€ïŒ
0.25éééšãæ·»å ããå åã«æ¹æãããããã
ããªã¢ãããã€ã«ã äžã«å¡åžãã70âã®ã®ã¢ãª
ãŒãã³ã§20åé也ç¥ãç²çå€å±€ã®åã¿ã50ÎŒïœ
ã®è²Œä»å€ãåŸãã (B) 貌ä»å€ïŒããŒãå€ïŒã®æ§èœè©äŸ¡ïŒæ¬å®æœäŸ(A)
é ã§åŸããã貌ä»å€10cm2ãè±æ¯åŠçããæ¥æ¬çœ
è²çš®å®¶å ã®èéšã«è²Œä»ããè¬ç©è¡äžæ¿åºŠã®çµæ
å€åã枬å®ãããçµæã¯è¡šïŒã«ç€ºãã æ¯èŒäŸ 13 (A) åžåä¿é²å€ãå ããªãã€ãããšä»¥å€ã¯å®æœäŸ
11(A)é ãšåæ§ã«ããã (B) å®æœäŸ11(B)é ãšåæ§ã«è¡ã€ãããã®çµæã¯è¡š
ïŒã®éãã§ãã€ãã
éšåã³ãã«ãã³æš¹è45éééšã®æ··åç©ã®10éé
ïŒ ã·ã¯ããããµã³æº¶æ¶²100éééšã«å¯Ÿãã€ãœãœ
ã«ãããžãã€ãã¬ãŒãïŒISDNïŒã®30ééïŒ å¡©
åã¡ãã¬ã³æº¶æ¶²3.704éééšãæ·»å ãããã«ã©
ãŠãªã³é žãžãããããŒã«ã¢ããïŒåžåä¿é²å€ïŒ
0.25éééšãæ·»å ããå åã«æ¹æãããããã
ããªã¢ãããã€ã«ã äžã«å¡åžãã70âã®ã®ã¢ãª
ãŒãã³ã§20åé也ç¥ãç²çå€å±€ã®åã¿ã50ÎŒïœ
ã®è²Œä»å€ãåŸãã (B) 貌ä»å€ïŒããŒãå€ïŒã®æ§èœè©äŸ¡ïŒæ¬å®æœäŸ(A)
é ã§åŸããã貌ä»å€10cm2ãè±æ¯åŠçããæ¥æ¬çœ
è²çš®å®¶å ã®èéšã«è²Œä»ããè¬ç©è¡äžæ¿åºŠã®çµæ
å€åã枬å®ãããçµæã¯è¡šïŒã«ç€ºãã æ¯èŒäŸ 13 (A) åžåä¿é²å€ãå ããªãã€ãããšä»¥å€ã¯å®æœäŸ
11(A)é ãšåæ§ã«ããã (B) å®æœäŸ11(B)é ãšåæ§ã«è¡ã€ãããã®çµæã¯è¡š
ïŒã®éãã§ãã€ãã
ãè¡šã
å®æœäŸ 12ã13åã³14
ãžã¯ãããšãã¯ãããªãŠã 50éšãåžåå©å€ïŒ
éšãã«ã«ãªè93éšãåäžã«æ··åããåçç¶ã«æ圢
ããŠåå€ãšããããã®åžåæ§ã家å ãçšããŠè¡äž
æ¿åºŠããè©äŸ¡ããã家å ã«äžèšåå€0.25ïœãèé
ããæäžããæäžåŸçµæçã«è³ä»éèããæ¡è¡ã
ãŠãè¡æŒ¿äžè¬ç©æ¿åºŠã枬å®ãããè¡æŒ¿äžãžã¯ãã
ãšãã¯ãããªãŠã ã®æž¬å®ã¯ãè¡æŒ¿ãããã³ãŒã³ã§
æœåºåŸæœåºç©ãã¬ã¹ã¯ãã¹ãã°ã©ãã€ïŒECDïŒ
ã§æž¬å®ããã æ¯èŒäŸ 14 åžåå©å€ãæ·»å ããªã以å€ã¯å®æœäŸ12ãšåæ§ã«
ããŠåå€ãäœè£œãããã®åžåæ§ãè©äŸ¡ãããçµæ
ãè¡š10ã«ç€ºãã
éšãã«ã«ãªè93éšãåäžã«æ··åããåçç¶ã«æ圢
ããŠåå€ãšããããã®åžåæ§ã家å ãçšããŠè¡äž
æ¿åºŠããè©äŸ¡ããã家å ã«äžèšåå€0.25ïœãèé
ããæäžããæäžåŸçµæçã«è³ä»éèããæ¡è¡ã
ãŠãè¡æŒ¿äžè¬ç©æ¿åºŠã枬å®ãããè¡æŒ¿äžãžã¯ãã
ãšãã¯ãããªãŠã ã®æž¬å®ã¯ãè¡æŒ¿ãããã³ãŒã³ã§
æœåºåŸæœåºç©ãã¬ã¹ã¯ãã¹ãã°ã©ãã€ïŒECDïŒ
ã§æž¬å®ããã æ¯èŒäŸ 14 åžåå©å€ãæ·»å ããªã以å€ã¯å®æœäŸ12ãšåæ§ã«
ããŠåå€ãäœè£œãããã®åžåæ§ãè©äŸ¡ãããçµæ
ãè¡š10ã«ç€ºãã
ãè¡šã
ïŒçºæã®å¹æïŒ
æ¬çºæã«ããã°ããã®ããã«ãèèªé
žãžã¢ã«ã
ããŒã«ã¢ãããåžåä¿é²å€ãšããŠè£œå€äžã«å«æã
ããããšã«ãããè¬ç©ã®çµç®ãããã¯çµç²èåžå
æ§ã«æ¥µããŠåªãã補å€ãåŸããããè¬ç©ã®åžåæ§
ãåªããŠãããããå¿ èŠãªè¬çå¹æãåŸãããã«
åŸæ¥ã®ããã«å€§éã®è¬ç©ã補é äžã«å«æãããå¿
èŠããªããçšããããåžåä¿é²å€ã¯ç®èãç²èã«
察ããåºæ¿æ§ããªããããé·æé貌ä»ããŠããã¶
ããçããªããè¬ç©ãå€è³ªãããããšããªããã
ãã«ãåžåä¿é²å€ãåå ãšãªã€ãŠè¬ç©ãæåºãã
ããããŒã補å€ã®ç²çç©æ§ãäœäžããããšããª
ãããã®ãããªè£œå€ã§ã¯ãçš®ã ã®è¬ç©ãçµç®ã»çµ
ç²èåžåãããããšãã§ããããã®ãããå«æã
ããè¬ç©ã®çš®é¡ã«ããåçš®ã®å»ççšã«å©çšããã
ãã
ããŒã«ã¢ãããåžåä¿é²å€ãšããŠè£œå€äžã«å«æã
ããããšã«ãããè¬ç©ã®çµç®ãããã¯çµç²èåžå
æ§ã«æ¥µããŠåªãã補å€ãåŸããããè¬ç©ã®åžåæ§
ãåªããŠãããããå¿ èŠãªè¬çå¹æãåŸãããã«
åŸæ¥ã®ããã«å€§éã®è¬ç©ã補é äžã«å«æãããå¿
èŠããªããçšããããåžåä¿é²å€ã¯ç®èãç²èã«
察ããåºæ¿æ§ããªããããé·æé貌ä»ããŠããã¶
ããçããªããè¬ç©ãå€è³ªãããããšããªããã
ãã«ãåžåä¿é²å€ãåå ãšãªã€ãŠè¬ç©ãæåºãã
ããããŒã補å€ã®ç²çç©æ§ãäœäžããããšããª
ãããã®ãããªè£œå€ã§ã¯ãçš®ã ã®è¬ç©ãçµç®ã»çµ
ç²èåžåãããããšãã§ããããã®ãããå«æã
ããè¬ç©ã®çš®é¡ã«ããåçš®ã®å»ççšã«å©çšããã
ãã
第ïŒå³ã¯æ¬çºæããŒã補å€ãšçµç®åžåä¿é²å€ã
å«æããªãããŒã補å€ãšããããã家å ã®ç®èè¡š
é¢ã«è²Œä»å€ãããšãã®è¬å€ã®è¡äžæ¿åºŠã®å€åã瀺
ãã°ã©ãã§ããã
å«æããªãããŒã補å€ãšããããã家å ã®ç®èè¡š
é¢ã«è²Œä»å€ãããšãã®è¬å€ã®è¡äžæ¿åºŠã®å€åã瀺
ãã°ã©ãã§ããã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ è¬ç©ããã³è©²è¬ç©ã®åžåä¿é²å€ãå«æããçµ
ç®ã»çµç²è補å€ã§ãã€ãŠã 該åžåä¿é²å€ãèèªé žãžã¢ã«ãããŒã«ã¢ããã§
ããã 該èèªé žã®ççŽ æ°ãïŒã15ã§ããã çµç®ã»çµç²è補å€ã ïŒ åèšåžåä¿é²å€ã0.01ã30ééïŒ ã®å²åã§å«
æããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒã®çµç®ã»çµç²
è補å€ã ïŒ ããŒã補å€ãããã補å€ãããã補å€ãè»è
å€ãã¯ãªãŒã 補å€ãå£è å€ãç¹éŒ»å€ãç¹çŒå€ãã
ã³åå€ã®ãã¡ã®å°ãªããšãäžçš®ã§ããç¹èš±è«æ±ã®
ç¯å²ç¬¬ïŒé ã«èšèŒã®çµç®ã»çµç²è補å€ã ïŒ åèšè¬å€ããã³è©²è¬ç©ã®åžåä¿é²å€ãã¢ã¯ãª
ã«ç³»ç²çå€ãŸãã¯ãŽã ç³»ç²çå€ã«å«æããããã®
ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ãªãã第ïŒé èšèŒã®
çµç®ã»çµç²è補å€ã ïŒ åèšã¢ã¯ãªã«ç³»ç²çå€ããççŽ æ°ïŒã12ã®ã¢
ã«ãã«åºãæããïŒã¡ã¿ïŒã¢ã¯ãªã«é žã¢ã«ãã«ãš
ã¹ãã«ã®ïŒå ±ïŒéåäœããã³ïŒãŸãã¯ççŽ æ°ïŒã
12ã®ã¢ã«ãã«åºãæããïŒã¡ã¿ïŒã¢ã¯ãªã«é žã¢ã«
ãã«ãšã¹ãã«ãšä»ã®å®èœæ§ã¢ãããŒãšã®å ±éåäœ
ã§ããã該ç²çå€äžã«ïŒã¡ã¿ïŒã¢ã¯ãªã«é žã¢ã«ã
ã«ãšã¹ãã«ãïŒå ±ïŒéåæåãšããŠ50ééïŒ ä»¥äž
ã®å²åã§å«æãããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒ
ã®çµç®ã»çµç²è補å€ã ïŒ åèšè¬ç©ããã³è©²è¬ç©ã®åžåä¿é²å€ãå«æ°Žåº
å€ã«å«æããããã®ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé
ãªãã第ïŒé èšèŒã®çµç®ã»çµç²è補å€ã ïŒ æ¯æäœã®çé¢ã«åèšè¬ç©ããã³åèšåžåä¿é²
å€ãå«æ°Žåºå€ã«æ··åããè¬ç©å«æå±€ãèšãããã
ç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒã®çµç®ã»çµç²è補
å€ã ïŒ å«æ°Žåºå€ãïŒã90ééïŒ ã®å²åã§æ°Žåãå«æ
ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ãªãã第ïŒé ã«èšèŒã®
çµç®ã»çµç²è補å€ã
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP18809585 | 1985-08-26 | ||
JP60-188095 | 1985-08-26 | ||
JP60-294568 | 1985-12-26 | ||
JP60-294570 | 1985-12-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS62228027A JPS62228027A (ja) | 1987-10-06 |
JPH0533929B2 true JPH0533929B2 (ja) | 1993-05-20 |
Family
ID=16217610
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP18134086A Granted JPS62228027A (ja) | 1985-08-26 | 1986-08-01 | çµç®ã»çµç²èè£œå€ |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS62228027A (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20150110818A (ko) * | 2013-02-12 | 2015-10-02 | 믞ì°ë¹ìëŽí€ ê°ë¶ìí€ê°ìŽì€ | ìì¹ ì ìŽ ì¥ì¹ |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2512804B2 (ja) * | 1989-07-14 | 1996-07-03 | ç©æ°ŽååŠå·¥æ¥æ ªåŒäŒç€Ÿ | çµç®åžå貌ä»å€ |
JPH07309755A (ja) * | 1994-05-20 | 1995-11-28 | Nichiban Co Ltd | æçèè¬è²Œä»å€ |
EP0788794A4 (en) * | 1994-08-09 | 2000-06-28 | Tsumura & Co | COMPOSITION FOR PREPARATION FOR EXTERNAL USE |
JPH08133974A (ja) * | 1994-11-04 | 1996-05-28 | Sekisui Chem Co Ltd | çµç®åžå貌ä»å€ |
CN1210463A (zh) * | 1996-02-07 | 1999-03-10 | æ ªåŒäŒç€ŸæŽ¥æ | éæåæ°¯è¬é žé ç氎溶液以åå®çè¯ç©ç»åç© |
US8623387B2 (en) | 2007-11-22 | 2014-01-07 | Medrx Co., Ltd. | External preparation composition comprising fatty acid-based ionic liquid as active ingredient |
-
1986
- 1986-08-01 JP JP18134086A patent/JPS62228027A/ja active Granted
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20150110818A (ko) * | 2013-02-12 | 2015-10-02 | 믞ì°ë¹ìëŽí€ ê°ë¶ìí€ê°ìŽì€ | ìì¹ ì ìŽ ì¥ì¹ |
Also Published As
Publication number | Publication date |
---|---|
JPS62228027A (ja) | 1987-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5891920A (en) | Medicinal adjuvants consisting of N-subsitituted-o-toluidine derivatives, and percutaneously absorbable preparations comprising the adjuvants | |
JPH02202814A (ja) | å£è ç²è貌ä»è£œå€ | |
JPH02202813A (ja) | çµç®åžåè£œå€ | |
JP4799783B2 (ja) | 䌞瞮æ§å€çšè²Œä»å€ | |
JP3170304B2 (ja) | ãšããªãŸã³ãŸãã¯ãã«ããªãŸã³çµç®åžåè£œå€ | |
JPH0533929B2 (ja) | ||
JPH0753671B2 (ja) | çµç®ã»çµç²èè£œå€ | |
JPH0429927A (ja) | 貌ä»å€ | |
JP3276194B2 (ja) | å»ççšè²Œä»å€ | |
JP3193161B2 (ja) | çµç®åžåæ§è£œå€ | |
JPH07103016B2 (ja) | 貌ä»å€ããã³ãã®è£œé æ¹æ³ | |
JPH0413617A (ja) | 貌ä»å€ | |
JPH07233050A (ja) | å€çšè²Œä»å€ | |
JP2003119132A (ja) | ãã©ãã©ã¹ãçµç®åžå貌ä»å€ | |
JPH01233212A (ja) | 貌ä»å€ | |
JPS62240614A (ja) | 貌ä»å€ | |
JPS62103015A (ja) | çµç®ã»çµç²èè£œå€ | |
JPS62240613A (ja) | 貌ä»å€ | |
JP3192765B2 (ja) | ããŒãè£œå€ | |
JPH0753670B2 (ja) | çµç®ã»çµç²èè£œå€ | |
JPH04202140A (ja) | çµç®åžåè£œå€ | |
JP3132838B2 (ja) | å£è ç²èé©çšè£œå€ | |
JPH05186371A (ja) | çµç®åžåè£œå€ | |
JP3224582B2 (ja) | çµç®åžåè£œå€ | |
JP3176400B2 (ja) | è¬ç©ã®è¡šç®çŽ°èå±€ééä¿é²å€ããã³çµç®åžåè£œå€ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Cancellation because of no payment of annual fees |